Knowledge

talk:WikiProject Pharmacology/Archive 14 - Knowledge

Source šŸ“

2452:
donation centers, my first thought isn't "fuck you for asking for my help, vampires," even if I know I can't find time to come in at the moment. And, as a result, I don't pretend to be an "active" blood donor if I haven't given in a long while. It just feels extreme to have a powerfully negative, emotional reaction to a simple, kindly-put reminder that the project exists, and I don't understand how it can be offensive to be moved to "inactive" when you're not, well, active. I don't think that the majority of users notified of their inactivity would react that way. Is there really not a kind way to do it? I disagree that this is akin to giving a "thumbs up or thumbs down" to an editor's contributions; rather, we're discussing the frequency of an editor's activity. And, how else (but an editor's activity) should we discuss how
2437:
those who have been interested in a project, along with providing a way for editors to communicate with one another within the project. But I continue to feel strongly that it should have nothing to do with giving thumbs up or thumbs down on any one editor's contributions. If anyone were to tell me something like "In my opinion, you need to be making more edits in such-and-such a topic area", my reaction would be "I'm a volunteer, so fuck you!". I try as best as I can to avoid saying divisive things out loud on-wiki, but that is what would go through my mind. --
3039:
At first I presumed this was meant to say 'selective agonist', as I haven't often heard the former term being used. But upon searching I found an article published in Nature that uses the term in its title, and I can't imagine it's very likely that the editors of Nature wouldn't have corrected a terminological error in a publications title. Either way, I am fairly certain that the content of the statement is not correct, in that Zopiclone, for example, acts indiscriminately, as a full agonist, at four of the five alpha subunits of the GABAA receptor -
445:. Some of those results are grouped under the same NDA/ANDA numbers, but a few of those results (specifically, the generic drug names), when clicked, display a large sub-list of different amphetamine pharmaceuticals with different ANDA numbers. Restoring that functionality would be ideal since any pharmaceutical drug that (1) has been in use for a long time, (2) is currently commonly prescribed in the United States, and (3) is no longer patented will have a similarly large number of search results as those for amphetamine. 3800: 1875:(as part of an activity update), Beetstra noted that "this was started years ago, and has been totally unmaintained." Before I proceed further with maintaining an old policy, I wanted to get an idea of what the other members of the project thought! Do you see a benefit to updating the list and posting on inactive user's talk pages? If we are to update them, how should we do it? Should the definitions for active/inactive be changed, or eliminated altogether? The template I've used is the following: 646: 2471:. Is this definition of "activity" preferable to the more lenient guidelines we already have? For people that don't edit at all, the current criteria give 6 months for a user to make an edit (just one!) to still be counted as "active." Even for "reasonably active" users, we allow a 3 month period for a user to make an edit. A every 30 day requirement for "active" status currently only applies to users with over 1,000 edits/month, and is still more lenient by requiring only 1 edit instead of 5.ā€• 31: 2907: 2851: 1343: 595: 502: 2875: 1757:
needs credentials to edit Knowledge. All due respect, but that question remains unanswered. I point this out because I've started to notice a fairly substantial number of errors on pages related to pharmacology, and because there appear to be restrictions on who can edit that content. How is consideration given as to the best way to balance good quality information, against obstructing corrections where there are errors on these articles? Cheers
5745:
elements and other basic substances you would encounter in your chemistry education, chemicals encountered in everyday life (e.g. in detergents, food additives or hair gel) as well as more niche substances such as pharmaceuticals, polymers, pollutants, biologically important materials, etc. Are there any specific collections of substances you would recommend us to look at? Please post any suggested lists or databases below. Many thanks,
4838:
elements and other basic substances you would encounter in your chemistry education, chemicals encountered in everyday life (e.g. in detergents, food additives or hair gel) as well as more niche substances such as pharmaceuticals, polymers, pollutants, biologically important materials, etc. Are there any specific collections of substances you would recommend us to look at? Please post any suggested lists or databases below. Many thanks,
3083:," as in "affecting some things and not others," of which the term "specific" (meaning "belonging or relating uniquely to a particular subject") is an improper approximation of. I've corrected the area you've mentioned, and made a few more edits to the article, which could still use a lot of work! For the future, when you have a concern about an article, you can bring it up on the article's talk page; for the zaleplon article, that is 2863: 1481: 2499: 1013: 1379: 684: 2625:. It's been my experience that many pages with this tag (perhaps even most) don't actually need attention from an expert, and especially if it's been tagged for years, the problem may have been solved. Please consider looking through the tagged articles, removing stale/inexplicable tags, and bringing a short list of the ones that need particular attention back to this page. 326:), can have multiple NDA's (Idelalisib: 206545 AND 205858). this leads to two different pages (for same product), and while the latest label is identical, the review report and the letter (containing post marketing requirements) are not! Conclusion: INN for Usfda is not enough, compared to EMA, a list of NDA's would be more complete. 1609:, noting the portals they maintain, so that those portals are skipped by the maintenance pass. Currently, we are interested in upgrading neglected and abandoned portals. There will be opportunity for maintained portals to opt-in later, or the portal maintainers can handle upgrading (the portals they maintain) personally at any time. 5172:
subpages, indicating missing redirects and missing articles. I added a new section to the WikiProject's home page called "Create articles" which points to this. If anyone is interested in creating stubs or just pondering the statistics, here are the number of unrecognized words on each sublist, which
4265:
subpages, indicating missing redirects and missing articles. I added a new section to the WikiProject's home page called "Create articles" which points to this. If anyone is interested in creating stubs or just pondering the statistics, here are the number of unrecognized words on each sublist, which
3917:
Furthermore, I'm really interested in expanding the articles on both to include the historical significance/data/uses/discovery/etc. but I'm not really sure where to start - it seems really daunting turning a stub into a full fledged article. Are there any examples of "intermediate" articles that are
2138:
I second DMacks here. As I said elsewhere, I can see advantages in moving generally inactive users, but this stick method is certainly not encouraging .. moreover, this list is not maintained for 9 odd years, and now you ā€˜demoteā€™ active editors who did not edit in the field (by whatever measure) for
5744:
from Wikidata and others to compile a list of what we consider to be the one million most important chemicals. This list will be used to prioritize what we look at for both Wikidata and Knowledge, and possibly other external groups that interact with us. These chemicals could include things like the
4837:
from Wikidata and others to compile a list of what we consider to be the one million most important chemicals. This list will be used to prioritize what we look at for both Wikidata and Knowledge, and possibly other external groups that interact with us. These chemicals could include things like the
2049:
on the whole idea. Why not retitle the categories "participants" and "highly active participants", with a "thank you for being so active" message upon promotion (reward) and just a "we notice you have not been highly active lately" (rather than feeling like demotion/exclusion just not the positive).
1931:
the implementation of the existing policy, clearly listed above the participants list, and think that adding a notice to their talk pages is helpful. Such is likely to encourage some people to start contributing to the project again. Perhaps add "If you plan to contribute, please return your name to
1670:
Hi, I am a current student in the pharmacy field, and I am currently researching the completeness of drug Knowledge articles. I stumbled upon your project page and was wondering how long this group has been going. Also the credentials of your main editors. I am new to Knowledge editing and am trying
3038:
The Zaleplon article states "Zaleplon, like zolpidem, zopiclone, or eszopiclone, are all specific agonists at the benzodiazepine GABAA Ī±1 sub-receptor site.". There is no citation, and I am uncertain about use of the term 'specific agonist'. Can someone please educate me as to the use of this term?
2342:
It does sound "negative" to suggest that someone is being inactive, but isn't there an implied sense of duty to be counted as an active member of a group? At some point, we have to call a spade a spade: is anyone arguing that the current inactivity criteria doesn't actually represent inactivity, or
2319:
WP:MED posts a thanks/note to editors who are highly active within the past year, unrelated to whether they sign onto the project. A "pure carrot". WP:PHARM could tighten the wording of its carrot (or reduce the pain of the stick) by identifying the list as "highly active within the past month" (or
2148:
I agree with other editors that a carrot, not stick, approach is the way to go. But frankly, nobody should care about making sure that active lists are purged of anyone who is inactive (I'm saying that in general, not just here). There are things ā€“ like articles! ā€“ on Knowledge that need to be kept
2815:
to include category-, disambig-, draft-, file-, portal-, project-, template-, and redirect-class ratings for pharmacology-related pages and created the corresponding categories. So, in a nutshell, our project's article/page rating template now includes categorization for those subject page types.
2185:
I don't think the point ever was for the sake of the list itself; rather, the list was a means to an ends of providing motivation for the purposes of editor retention. Do you think we should remove the "active" and "inactive" categories entirely, and simply have a list of members? DMacks suggested
1756:
Intend this with the upmost respect, but realize it might be impossible to say without sounding a bit rude, I really don't mean it to be. I think the question above needs to be re-addressed, because the question was what the credentials of the main editors of this group are, not whether or not one
2436:
Good question. In my opinion, it ranks very, very low among the ways that Knowledge does anything to be of service to our readers. Kind of not even worth having as much discussion as we are having here. But I think the one good that it does is to provide a bit of acknowledgement among editors for
2451:
It is also worth considering the utility of listing "inactive" users. Perhaps these are people we can reach out to and remind them about the project, as per my suggestion above. I think that Tryptofish's response to a request for volunteerism is a bit extreme; I mean, when I get calls from blood
192:
I will try to explore if this can be done more general (e.g. using inn or tradename) in the next weeks. However, it might definitely need an update of the implementation of the drug box use of 'us-license' parameter. And of course - you need to be happy with accessing the pretty expert-like drug
3897:
But I noticed now that the redirect (lente insulin) is different from the format of the stub name that already existed for the similar type (just "ultralente"). Which is preferable - basically, should one or the other be moved, or it doesn't particularly matter? If neither needs moved, should a
3317:
For US the pattern that I see is some but not all states have "healthcare" articles. More states have "list of hospital" articles. Some states have "department of health" articles. I am not opposed to pharmacy law articles but I have my doubts that these can stand when the regional "healthcare"
736:
So, if you're an active editor at WT:PHARM and edit drug articles on a fairly regular basis, your input at the next nomination would be invaluable. Moreover, if any of you intends to nominate a drug article at FAC at some point in the future, reviewing another pharmacology nomination as well as
403:
Thank you for bringing your concerns to our attention. We have had some recent changes to our Drugs@FDA website. Your inquiry has been forwarded to experts within the Agency for input and assistance. When we receive a response we will forward it to you, or they may contact you directly. Please
3753:
that classifies different types of covalent inhibitors. There are at least 8 different classifications of "suicide inhibitors" but they are more accurately classified as irreversible inhibitors. This term is not widely used as when you search with quotes "irreversible inhibitor" and "suicide
2273:
I think that if an editor previously put themselves on the active list, having someone else move them to inactive is sort of like saying that we don't think you're doing enough any more. That sounds negative. But I'm aware that active/inactive is very common at many WikiProjects. And it's an
1841:
It occurs to me to add another point. The way that Knowledge is set up, the concept of editors needing to have "credentials" does not apply at all. A big part of this is that everyone has the right to edit anonymously, and that is something that the community cares about a lot. As far as I'm
1890:
A possible pro to maintaining the old standard includes that it may help otherwise inactive members remember that our project exists, and perhaps spur them to make a contribution to a WikiProject Pharmacology article. On the other hand, as Beetstra pointed out on their talk page, it may be
3578:
Absolutely! On the Talk page of the article, add the term {{WikiProject Pharmacology}} to the top of the page. Someone will be by (eventually) to look the page over. If you'd like a more thorough (and expeditious?) review, consider contacting a WP:Pharm editor directly or paste the page
3966:
That's basically exactly what I needed - I'll keep the style guide up and try to follow it when expanding the two articles, and I've moved them in accordance with the guide. The list of "C articles" is also helpful for some guidance on what to shoot for when expanding. Thanks again!
1580:
At present, we are gearing up for a maintenance pass of portals in which the introduction section will be upgraded to no longer need a subpage. In place of static copied and pasted excerpts will be self-updating excerpts displayed through selective transclusion, using the template
2393:
be appreciative. I don't think that means that we shouldn't encourage people to contribute, however. And if everyone is counted as "active," then activity loses its utility. A participant list that doesn't list actual participants is meaningless. If I volunteer once with the
1730:
As Tryptofish said, the only "standards" are those that apply to the project as a whole. The two standards cited are must-reads, and will definitely make contributing easier. If you have any questions, feel free to drop by here or on my talk page. Welcome to Knowledge!
2292:
FYI, WP:MED does what I think is about the max one should do - move editors who have not edited AT ALL for some time (they have a month). Anything else says ā€˜you are not doing enough for us). (Did someone now locate a proper discussion regarding these rules?).
304:
Yes contact FDA please. IMO we could use the automated link (URL) to INN-licence info, so if that is "expert-like drug overview pages", that be so (re Wowbagger2). Code change no issue; did so recently with EMA licence (which goes by INN + per-article exception
2072:
the current criteria as giving more leeway to those who wander away from WP as a whole for many months still being "active" whereas those who are highly active on the site have a higher activity requirement in the field. I think either one is highly active
3754:
inhibitor" in pubmed you get 2203 and 275 results, respectively. I think changing the name as previously mentioned and adding "suicide inhibitor redirects here" would be appropriate. The agonist and antagonist pages are not as relevant to the discussion
2210:
Actually, I don't have a strong opinion about that, either way. Just that the approach should be "carrot". Probably, that means doing away with "inactive" in favor of a more positive name, but what the name or location should be doesn't matter to me.
3637:
does a good job of reviewing the subject and does not mention suicide inhibitors as it is currently referred to on wiki and is the current best review of this subject from a perspective of medicinal chemistry. I propose a new page to combine stubs
3131:
I've noticed that there don't appear to be any pages pertaining to pharmacy law in US states (or at the national level). There's a lot of work on gun laws and LGBT rights by state, and I'm not sure if this would be better suited to the purview of
883:
The drugbox has an external link to generate and display a 3D model using JSmol. The 3D image fails to be generated properly for larger chemical structures - they render completely planar. Smaller chemical structures seem OK. See for example
3862:
leak in India has killed 13 people and injured many more. As such, there's been a surge in editing on the 'Health effects' section of that page, not all of it to our usual standards. I normally try to keep away from health sections as I leave
862:
I don't think there are clearly defined criteria - it is mostly a judgement call. I would certainly exclude from listing in this template any article that does not discuss a laxative effect. Therefore, I have removed the link to linseed. --
2248:
has a list without active/inactive categorization. Perhaps we could gain some insight on what WP:PHARM should do by asking members of these groups for their input, on how their participant lists are working out for them. Thoughts on that as
892:(MW 418) which looks fine. Has this been discussed before? Am I correct in thinking that it fails above a certain molecular weight? Would it be possible to disable the link for drugs with molecular weights above the cutoff? -- 1621:. On April 17th, the Portals WikiProject was rebooted to handle the revitalization of the portal system. On May 12th, the RfC was closed with the result to keep portals, by a margin of about 2 to 1 in favor of keeping portals. 5141:
So, on balance, use in the primary and secondary sources varies, but with a tendency to use the no-comma form for the significant majority. My feeling, therefore, is that a global change or convention does more good than harm.
4234:
So, on balance, use in the primary and secondary sources varies, but with a tendency to use the no-comma form for the significant majority. My feeling, therefore, is that a global change or convention does more good than harm.
1994:), whose intention it was to "upgrade the project" by creating the activity differences, and maintaining them. The suggestion appeared to have passed without much discussion of the specifics at the time. I hope that helps!ā€• 765: 692: 3748:
article does not need much on that page but the classifications of types of covalent inhibitors are left out and would fit better on its own page. I would advise looking at the first figure in the referenced paper
2274:
incredibly unimportant detail for me. I don't think it's worth doing research at other projects, but if it's you and not me doing it, that's up to you. I think the best place to ask about it would actually be at
1570:
The reason I am contacting you is because there are one or more portals that fall under this subject, and the Portals WikiProject is currently undertaking a major drive to automate portals that may affect them.
2742:. It looks like it's easy to find sources about drug titration in specific instances, but information about the general concept seems to be harder to identify. Can anyone help out with a good source or two? 2098:
Hmm. I suppose that proposal would change the emphasis to providing positive feedback (carrot) as opposed to negative feedback (stick). What about doing both--i.e., adding a third category for "high active
1913: 550: 492: 409:
Health Canada responded specifically to the issue I highlighted (unlike the FDA), but they essentially said that the behavior was intentional and they weren't going to change it, so no luck there either.
5018:. Lest we make a mistake, and to correct previous mistakes, this should probably be undertaken on a case-by-case basis. I went back and forth between weak support and weak oppose 3 times, for reference.ā€• 4111:. Lest we make a mistake, and to correct previous mistakes, this should probably be undertaken on a case-by-case basis. I went back and forth between weak support and weak oppose 3 times, for reference.ā€• 636: 3790: 585: 3556:
I've been done some work recently on combination vaccines, and many of the pages I have been working on are not listed under Wikiprojects:Pharmacology. Can I nominate these pages for review somehow?
2375:
Since you asked me, no. I think we are all volunteers here, and nobody has an obligation to do more than what they feel like doing. I think we should always be appreciative of whatever we can get. --
3842: 2518: 611: 525: 1859: 1126:
too apparently). Of course, if JSmol breaks that would be visible to me. But I'm not happy to check 15k external linksĀ ;-). At least, when an image is knowingly wrong, "we" should tag it with
2329: 400:
Thank you for writing the FDA. Please accept this response from the Small Business and Industry Assistance, Division of Drug Information, in the FDAā€™s Center for Drug Evaluation and Research.
1562: 2574: 2552: 2468: 2236:
as well (correct me if I'm wrong). I'm curious: why do you (or others) think that the "stick" method of having an "inactive" categorization isn't a good strategy for promoting retention?
1618: 107:
Just to make you aware, that apparently FDA seems to have changed the URL for searching NDA's or so. Clicking onto the us-license link in drug boxes does seem to not to work properly ...
5103:
with 0 references; GSK-789,472 with 0 references (will tag that one for deletion ... one primary reference, and that does mention the drug but not that code name), no secondary sources.
4196:
with 0 references; GSK-789,472 with 0 references (will tag that one for deletion ... one primary reference, and that does mention the drug but not that code name), no secondary sources.
3675: 758: 3106: 1836: 1159:
example is about a small molecule, it does not seem to be related to molecule size. 4. We should gather more examples of bad rendering. (Please do so by entering the SMILES string to
2837: 3624: 362:, I realized it was you that sent an email to the FDA about the non-functional drug search links. Did you ever receive a response from them about this? If so, what did they say? 3719: 3688: 3335: 3312: 3237: 3185: 2706: 2692: 2596: 2564: 2540: 2512: 2490: 2417: 2384: 2287: 2268: 2220: 2205: 2143: 1851: 1772:
I don't think we've ever been surveyed. That said, the number of people who edit pharmacology articles on Knowledge is FAR larger than the number of people in this WikiProject.
1750: 669: 5151: 3403: 1596: 579: 5037: 3706: 3616: 3602: 2297: 2031: 2013: 1923: 4244: 3279: 3255: 1972: 4130: 2792: 2431: 2370: 2133: 2063: 4004: 3828:
in the "Today's articles for improvement" section for one week, beginning today. Everyone is encouraged to collaborate to improve the article. Thanks, and happy editing!
3373: 2720: 1882:
Hi there! I've noticed that you haven't been active on WikiProject Pharmacology. Per our policies, your status has been moved from Active to Inactive, which you can view
1793: 3195: 1991: 1805:
No worries, that's a fair question to ask. Simply put, there are no "credentials" required; anyone is free to edit these articles. If you notice errors, feel free to be
3507: 3461: 1541: 5766:
contains ~13,500 drugs, of which ~4,000 are approved. The database is downloadable and can be filtered for approved drugs if 13,500 is too many for your purposes. The
4859:
contains ~13,500 drugs, of which ~4,000 are approved. The database is downloadable and can be filtered for approved drugs if 13,500 is too many for your purposes. The
3199: 1766: 1625: 856: 730: 5815: 5799: 3580: 2661: 1718: 1460: 1426: 1371: 1335: 661: 3978: 3961: 4908: 4892: 3417: 2770: 2158: 482: 466: 383: 345: 147: 1511: 212: 116: 3435: 2446: 2348: 1556: 1407: 821: 789: 419: 231: 4996: 4973: 3380:
Welcome to Knowledge, and to WikiProject Pharmacology! Let me know if you ever need any assistance with anything! There's tons of work to do, so feel free to be
3113: 3070: 3049: 2784: 2622: 1941: 1800: 1758: 1690: 2170:
Just to be clear, the "demotion" from active to inactive is 6 months for no contributions, 3 months if reasonably active, and 1 month if extremely active (: -->
2114:. I'm not aware of any data on how long other projects wait before making efforts to re-engage "inactive" users, or if other cut-offs or categorizations exist.ā€• 1250: 1172: 1099: 317: 290: 264: 161: 4089: 4066: 3780: 3763: 3735: 3479: 2086: 1308: 1223: 1142: 1117: 1809:
and fix them yourself, point them out on the talk page, or ask for assistance here. The "quality" of information should never be in much dispute, as long as
872: 2634: 2107: 691:
Now that this article is a GA, I intend to re-nominate this article at FAC sometime within the next 2 weeks. When the following is no longer a red link ā€“
3155: 2171:
1000 edits). You don't think that there are some users that may be motivated by the "stick" method, as Klbrain commented? I.e., the internal dialogue of,
1431:
As a suggestion, that section ā€“ in addition to other very long level 3 sections in the article ā€“ would look less congested if level 4 section headers and
1282: 1090:
has the same setup; together in their 17k articles, some 90% have SMILES input used this way. Automatic suppression (by molar weight) to be considered. -
166:
I could. It would however need an update of how WP is accessing drug information at drugs@fda: at least with the NDA number, you can link to their website
5754: 3821: 827: 3654:. These are all based on covalent inhibition yet there is no page for this. I will be working on this in sandbox first as I am new at this and am using 4847: 3292: 797: 94: 89: 84: 72: 67: 59: 5014:), I'm not sure if we can paint a broad brush. Some drugs are named with a space instead of a hyphen (or without a space as all), as I just fixed for 4107:), I'm not sure if we can paint a broad brush. Some drugs are named with a space instead of a hyphen (or without a space as all), as I just fixed for 3945: 3121: 3061: 3986: 3443: 3296: 1986:
That's a fair question; I think historical context is worth looking at too. I did a little digging, and the earliest mention I can find is a post by
1725: 1678: 1612: 1516: 3934: 1660: 3409: 3361: 3349: 2751: 1638: 1264: 737:
reading the reviews by other editors at that nomination will give you a good idea of what to expect and prepare for at your own FAC nomination(s).
3449: 1842:
concerned, if a Nobel Laureate makes an error in an edit, I'm going to fix it, and if a young child makes a good edit, I'm going to support it. --
3771:ā€“ Just to reiterate, I think it is important that a reasonably complete discussion of irreversible inhibitors be retained in the parent article. 3546: 3466: 3319: 2570: 2460: 1883: 1868: 1860: 901: 559: 4921:
Is there a standardized way for drugs that are only known by a company code? I've almost always seen it written as PREFIX-NUMBER (for example,
4014:
Is there a standardized way for drugs that are only known by a company code? I've almost always seen it written as PREFIX-NUMBER (for example,
3949: 5182: 4943: 3876: 2398:, and never again, am I still an "active participant?" Is there no utility to having a list of active and inactive participants of a project?ā€• 5100: 4193: 2956: 2951: 2926: 2921: 102: 4275: 4036: 1155:
JSmol rendering. 2. We have three examples of a wrong model showing (one could be improved by using a different SMILE string). 3. Since the
359: 4978:
What do you think would be a good way of doing this? Occasionally, I come across a page that can't be moved over another redirect, such as
4071:
What do you think would be a good way of doing this? Occasionally, I come across a page that can't be moved over another redirect, such as
3992: 2946: 515: 1697:
Hello, and welcome to Knowledge! As for credentials and standards, anyone is welcome to edit Knowledge constructively. You should free to
3816: 3565: 2941: 2173:"I want to be an active contributor, and my status will move to inactive if I don't do something. Therefore, I will make a contribution." 1605: 605:, which is within the scope of this WikiProject, has been nominated for merge. A discussion is taking place to see if it abides with the 1547:
I've replied there, and it looks to me to involve a couple of complexities, so it would be helpful if more editors would check on it. --
1439:
were used instead of bold article text to separate material on different subtopics (e.g., medications for different symptoms clusters).
2931: 2894: 2077:
or one isn't. Do we have data about editor retention for how long we (Wikiproject, or WP as a whole) waits before trying to lure back?
1528:, that is tagged) never got any response until I noticed it today and added yet a different option. I'd appreciate others' comments at 1187: 1039: 848: 2966: 2936: 2916: 2899: 832:
Are there some clearly defined criteria for which articles should be linked in pharmacology templates, and which should be excluded?
189: 173: 1886:. Don't be discouraged, though--we'd love to see you come back and contribute to the project! Let me know if you need any help! ~~~~ 3423: 1472: 1267:
to create and improve cannabis-related content runs through the month of April. WikiProject members are invited to participate. ---
5055: 4961: 4148: 4054: 2961: 2911: 2879: 2855: 2149:
current, but this isn't one of them. The greatest good would come from simply encouraging more editors to contribute actively. --
1891:
discouraging to editors to see their status change from active to inactive, possibly having the opposite of the intended effect.
47: 17: 4933:). I feel like it would be better to move those articles to PREFIX-NUMBER format. In other words, move GR-196,429 to GR-196429. 4026:). I feel like it would be better to move those articles to PREFIX-NUMBER format. In other words, move GR-196,429 to GR-196429. 219:
OK. Do other people here think DailyMed is better/enough? IMO, we'd want a list by INN (one can get that manually, through page
4964:
shows that there is currently mixed use, and it might therefore be worthwhile having some consensus to do this systematically.
4057:
shows that there is currently mixed use, and it might therefore be worthwhile having some consensus to do this systematically.
3057: 2889: 2884: 2867: 1665: 1529: 631: 574: 545: 5006:
merge. While I've rarely seen commas in the company code names too, and in those cases, I wonder if they are errors (like
4099:
merge. While I've rarely seen commas in the company code names too, and in those cases, I wonder if they are errors (like
441:
used to bring up the search page with the list of 37 results that you would see if you searched the term "amphetamine" on
700: 675: 616: 530: 508: 493: 2459:
On a related note, I've received a link to a bot-maintained list of "active" participants (defined differently than the
2343:
just that it can be demotivational to be told that you're inactive? Thank you for the suggestion of reaching out to the
1056:
hide the JSmol link, based on molar mass as is proposed, I'd like to read opinions; I can not judge that by myself. HTH.
395:
The FDA essentially never replied to the specific concern (the below message is the only response I ever got from them):
2697:
You all are awesome. Just three and a half hours later, and more than half the articles have already been looked at.
2577:? Unless we can transform the page into a sort of pure carrot? I don't know how WP:MED identifies highly active users.ā€• 2320:"active within the past 3 months") to clarify what the scope is (goes back to my dislike of differential thresholds). 3525:. Another editor and I are engaged in an edit war, so we need unbiased third-party feedback on the disputed content. 3112:
Thanks, not sure why it wasn't working earlier I had assumed only some could edit the talk page. My mistake. Cheers!
2810: 2795: 1626:
article in the current edition of the Signpost interviewing project members about the RfC and the Portals WikiProject
1287: 1133:
Given the small ferrocerene example, being big is not the only reason. Maybe someone contact the site maintainers? -
601: 586: 193:
overview pages, by clicking on 'us-license'. (In contrast, the 'daily med' link can provide consumer information).
5735: 2673:
Thank you for bringing this up! In the process of going through some of these articles and removing tags as well. ā€•
1686: 1644:
If you have any questions about what is happening with portals or the Portals WikiProject, please post them on the
1585: 1532:
so it can get resolved one way or another (and also whatever assessment/tagging the project feels is appropriate).
341: 208: 123: 3369: 3169: 2616: 2467:
than the current "active" criteria, only listing users with 5 or more edits within 30 days!), which you can find
4828: 3633:
and this could lead to the new/combined page. The chemistry of this will be detailed and a recent paper titled
2344: 2275: 1499: 5782:
exist for most approved drugs in the US and Europe, but also for obsolete/historical drugs. The website is
4875:
exist for most approved drugs in the US and Europe, but also for obsolete/historical drugs. The website is
3684: 3651: 3630: 3053: 2569:
Sorry for abandoning this discussion for a while, but how do people feel about simply blanking the current
1525: 1005: 308:
To consider asking: if we can download complete lists (like in spreadsheet), we can put that in Wikidata! -
269:
If I'm wrong about them having been contacted, I wouldn't mind sending them an email explaining the issue.
3522: 2758: 1631:
Since the reboot, the Portals WikiProject has been busy building tools and components to upgrade portals.
2422:
That raises the underlying question "what is the actual use of publicly listing those that are active?".
1655: 1294:
I have completely rewritten DLB; might someone check all of my usage of meds, as well as the wikilinks?
1237:, thanks for the info. It looks like size isn't the entire reason the rendering fails. I'll start using 609:
guidelines. If you would like to participate in the discussion, you are invited to add your comments at
523:
guidelines. If you would like to participate in the discussion, you are invited to add your comments at
3825: 3117: 1871:, I have taken the liberty of updating the participant list. However, after bringing up the topic with 1762: 1275: 38: 5019: 4112: 3925:
Apologies if this isn't the best place to ask these questions - but thanks in advance for your help!
3584: 3385: 3286: 3261: 3243: 3219: 3163: 3137: 3088: 2674: 2578: 2548: 2522: 2472: 2399: 2352: 2250: 2187: 2115: 2022: 1995: 1954: 1895: 1818: 1732: 1288: 1258: 627: 570: 541: 2244:
also has an inactive list (albeit, managed by a bot), but does not post on talk pages. In contrast,
5165: 4258: 3872: 3512: 3079:
article. To answer your question, my guess is that the writer meant to convey that the agonism is "
878: 606: 520: 3969: 3354:
I find pharmacology and biochem super interesting, cool to see a community of people who do too.
190:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=210259
174:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=209936
5159: 4916: 3881: 3715: 3702: 3643: 2850: 297: 5585: 5501: 5477: 5351: 5054:
with 258 references. Taking other examples (the first unique company code name I could find in
4678: 4594: 4570: 4444: 4147:
with 258 references. Taking other examples (the first unique company code name I could find in
3974: 3930: 3330: 3307: 3211: 3180: 2747: 2730: 2716: 2702: 2630: 2560: 1682: 1619:
RfC ("Request for comment") proposal was made to eliminate all portals and the portal namespace
1422: 1304: 337: 204: 2906: 301:
shows no hints either, a new issue. What I did was switch off Canada because it does not work.
5770: 5615: 5435: 5423: 5405: 5363: 5267: 5225: 4863: 4708: 4528: 4516: 4498: 4456: 4360: 4318: 4252: 4009: 3365: 3033: 1645: 1268: 1204: 723:) review and comment on a pharmacology nomination at FAC, it very likely will not be promoted 3478:; however, synthetic antioxidants are within this project's scope, so I'm liking this here: 2186:
the category of "highly active participants," with the removal of the "inactive" category. ā€•
2027:
that is indeed the post I was looking for. Not much more than a fleeting mention though. ā€”
442: 220: 5795: 5705: 5699: 5675: 5669: 5663: 5657: 5645: 5639: 5633: 5621: 5609: 5603: 5573: 5567: 5561: 5549: 5543: 5531: 5495: 5489: 5483: 5465: 5453: 5441: 5411: 5393: 5387: 5357: 5333: 5321: 5309: 5291: 5273: 5261: 5249: 5243: 5219: 5189: 4888: 4798: 4792: 4768: 4762: 4756: 4750: 4738: 4732: 4726: 4714: 4702: 4696: 4666: 4660: 4654: 4642: 4636: 4624: 4588: 4582: 4576: 4558: 4546: 4534: 4504: 4486: 4480: 4450: 4426: 4414: 4402: 4384: 4366: 4354: 4342: 4336: 4312: 4282: 4000: 3711: 3698: 3639: 3357: 3207: 3203: 3126: 3045: 2508: 2442: 2380: 2283: 2216: 2154: 1847: 1714: 1674: 1552: 1507: 1122:
I can not judge if JSmol produces nonsense/incorrect modules (ferrocerene had, I remember;
620: 563: 534: 478: 329: 196: 112: 3629:
A page titled "Covalent (enzyme) inhibitors" needs to exist. A small section exists under
8: 5729: 5591: 5555: 5519: 5447: 5429: 5417: 5375: 5345: 5339: 5327: 5303: 5297: 4822: 4684: 4648: 4612: 4540: 4522: 4510: 4468: 4438: 4432: 4420: 4396: 4390: 3868: 3483: 3413: 3242:
There are frequently pages for the relevant legislative acts; some of them are listed at
2862: 2780: 1521: 3190:
Thank you for the reply! I think that's a great page, but I'm thinking about pages more
5811: 5750: 5717: 4904: 4843: 4810: 3907: 3750: 3647: 3634: 3612: 3561: 3539: 3500: 2830: 2654: 1786: 1702: 1453: 1434: 1400: 1364: 1328: 1246: 897: 868: 836: 814: 782: 751: 459: 415: 376: 283: 257: 140: 1671:
to get a general idea of what the standards of your group are. Thank you in advance.
5787: 5711: 5627: 5597: 5579: 5537: 5525: 5513: 5507: 5471: 5459: 5399: 5381: 5369: 5315: 5279: 5255: 5237: 5231: 5213: 5207: 5201: 5195: 5147: 4969: 4880: 4804: 4720: 4690: 4672: 4630: 4618: 4606: 4600: 4564: 4552: 4492: 4474: 4462: 4408: 4372: 4348: 4330: 4324: 4306: 4300: 4294: 4288: 4240: 4062: 3968: 3957: 3926: 3759: 3671: 3663: 3655: 3431: 3323: 3300: 3251: 3215: 3173: 3080: 2743: 2712: 2698: 2668: 2626: 2556: 2111: 1937: 1494: 1413: 1295: 699:
if other editors from this WikiProject would comment/review the article against the
122:
Yes, that link has unfortunately been broken since around January or February 2017 (
5723: 5693: 5687: 5681: 5651: 5285: 5178: 4994: 4941: 4816: 4786: 4780: 4774: 4744: 4378: 4271: 4087: 4034: 3776: 3745: 3731: 3692: 3551: 3482:. There's currently a total of 7 sentences relevant to drugs in this article under 3457: 2766: 2555:. If you need something that's truly up to date, then that page does it for you. 2427: 2325: 2082: 2059: 1709:
as a way to get familiar with writing standards. And feel free to ask questions! --
1698: 1564: 1537: 1219: 1194: 1168: 1138: 1113: 1095: 946: 919: 766:
Knowledge:Featured article candidates/Beta-Hydroxy beta-methylbutyric acid/archive4
693:
Knowledge:Featured article candidates/Beta-Hydroxy beta-methylbutyric acid/archive4
313: 227: 157: 843:, despite no mention of pharmacological action in that article; but does not link 5791: 4953: 4884: 4046: 3996: 3864: 3853: 3474:
The scope of the problems with this article's comprehensiveness pertains more to
2807:
FYI: I just extended the range of acceptable inputs for the "class" parameter in
2504: 2438: 2376: 2337: 2279: 2227: 2212: 2180: 2150: 1843: 1810: 1710: 1706: 1548: 1503: 716: 656: 474: 428: 333: 200: 108: 3890:
to the glossary of insulin terms and made a stub at that link in line with what
3799: 404:
understand that response times may vary. Thank you in advance for your patience.
46:
If you wish to start a new discussion or revive an old one, please do so on the
3381: 3260:
All good things! However, I don't think these pages reflect pharmacy practice.ā€•
2776: 2739: 2735: 2245: 1987: 1806: 4983: 4076: 3691:. At the same time, I think an extensive summary should be left behind in the 2110:
on Knowledge. After all, if you can retain a high-output editor, you get more
5807: 5746: 5169: 4900: 4839: 4262: 3903: 3887: 3835: 3608: 3573: 3557: 3526: 3487: 3475: 3133: 3084: 2817: 2641: 2294: 2241: 2237: 2165: 2140: 2106:
focused on high-output users; i.e., users that are already spending a lot of
2051: 2028: 1981: 1920: 1872: 1814: 1773: 1637:
If you would like to keep abreast of what is happening with portals, see the
1603:
Maintainers of specific portals are encouraged to sign up as project members
1440: 1387: 1351: 1315: 1242: 893: 864: 852: 801: 769: 738: 729:
required 5 consecutive featured article nominations before being promoted in
720: 712: 671: 446: 411: 390: 363: 353: 270: 244: 222:). Note that our EMA link (Europe) works with INN (sometimes rewritten...). - 178: 127: 3318:
articles are so shabby. The most developed regional healthcare articles are
711:
unless editors who are familiar with the subject matter (i.e., editors from
5143: 4965: 4236: 4058: 3953: 3755: 3667: 3659: 3427: 3247: 1948: 1933: 1123: 885: 243:
Didn't you contact the USFDA about this issue earlier and get no response?
4929:). But something I've only ever seen here on wiki is PREFIX-NUM,BER (like 4022:). But something I've only ever seen here on wiki is PREFIX-NUM,BER (like 645: 5174: 5090: 4987: 4934: 4267: 4183: 4080: 4027: 3948:; you'll see some articles just a little further along. The pharmacology 3919: 3772: 3769:
I agree that the Enzyme inhibitor article does not need much on that page
3727: 3468: 3453: 2762: 2423: 2321: 2233: 2102:
My guess behind the intention there was that retention efforts should be
2093: 2078: 2055: 1533: 1232: 1215: 1164: 1134: 1109: 1091: 889: 726: 438: 309: 238: 223: 153: 5790:
is more machine friendly. ATC codes are also included in the Infobox. --
5776:
has a field for the Drugbank id, but I think these are quite incomplete.
4883:
is more machine friendly. ATC codes are also included in the Infobox. --
4869:
has a field for the Drugbank id, but I think these are quite incomplete.
3722:(mixing apples and oranges, enzymes and receptors are different beasts). 3295:
a few years ago but felt stumped for sources. With some other states in
3040: 1342: 5741: 5129: 5116: 5070: 5060: 5043: 5011: 4979: 4930: 4834: 4222: 4209: 4163: 4153: 4136: 4104: 4072: 4023: 3911: 3891: 1488: 1474: 1073: 1002: 653: 323: 169: 5783: 4876: 5106: 5080: 4957: 4199: 4173: 4050: 3810: 3518: 2395: 1156: 1081: 1031: 433:
The USFDA link used to link to the USFDA search page results for the
5007: 4100: 3814:, which is within this project's scope, has been selected as one of 3681:
I would suggest #1 and #2 would be OK but I would be opposed to #3:
2575:
Knowledge:WikiProject Directory/Description/WikiProject Pharmacology
2553:
Knowledge:WikiProject Directory/Description/WikiProject Pharmacology
5779: 4922: 4872: 4015: 3136:, but I was wondering if anyone wanted to collaborate on anything.ā€• 3076: 1498:
with another article. If you are interested, please participate in
910:. Here is some background on this; I have worked on this parameter. 5015: 4926: 4108: 4019: 3859: 3791:
One of your project's articles has been selected for improvement!
2175:
It seems reasonable to me, but that's only my personal viewpoint.
1524:
was never tagged for WP:PHARM and a year-old merge request (from
1314:
I'll take a look this weekend ā€“ possibly sooner if I have time.
3695:
article since the the subject of enzyme kinetics depends on it.
1919:
I have yet to see a discussion that initiated that ā€˜policyā€™. ā€”
1577:
The new design features are being applied to existing portals.
1480: 360:
Template talk:Infobox drug#licence_US parameter no longer works
4960:. A simple move is technically possible. A quick scan through 4952:
merge, which would also be consistent with similar drugs from
4053:. A simple move is technically possible. A quick scan through 4045:
merge, which would also be consistent with similar drugs from
560:
Template talk:R from trade_name#Requested_move_18_January_2018
3899: 844: 3922:
that I could look at to keep making baby step improvements?
3450:
Wikipedia_talk:WikiProject_Medicine#Level_of_reading_dispute
2573:
page, and redirecting to the bot-maintained list located at
519:. A discussion is taking place to see if it abides with the 5763: 4925:). I've also occasionally seen it written as PREFIXNUMBER ( 4856: 4018:). I've also occasionally seen it written as PREFIXNUMBER ( 3867:
stuff to the experts. I'd appreciate any help available. --
840: 2517:
Oh, this is awkward.. I'll uhh.. just go ahead and delete
5168:, I happened to notice there are a bunch of red links on 4261:, I happened to notice there are a bunch of red links on 3625:
Proposed merger of 4 pages concerning Covalent inhibitors
1386:. Excluding one typo that I fixed, nothing seemed amiss. 1108:
Thanks DePiep. So it does fail for all larger molecules?
796:
For those who haven't reviewed an article at FAC before,
2240:
thought it may be discouraging. Notably, I believe that
1151:
Let me rewrite this comment. 1. We have no example of a
2623:
Category:Pharmacology articles needing expert attention
2495:
Well, I hope nobody at this project asks for my blood.
956:(in the Identifiers section) for the link to JSmol. In 3480:
Knowledge:Featured article review/Antioxidant/archive1
798:
this is the "FAQ" page for reviewing articles at FAC
2738:has very kindly taken up my request to write about 731:
WP:Featured article candidates/Amphetamine/archive5
709:to get a pharmacology article promoted at FAC, and 5788:https://www.kegg.jp/kegg-bin/get_htext?br08303.keg 4881:https://www.kegg.jp/kegg-bin/get_htext?br08303.keg 3293:User:Bluerasberry/Healthcare in Washington (state) 3291:I think this is overly ambitious. I tried to make 1530:Talk:Radiopharmaceutical#March 2017 Proposed merge 1487:An article that you have been involved in editingā€” 1052:(set to "none" or "alternative SMILES" value). To 152:Could not find any wisdom at the FDA site. (help)- 3297:Category:Healthcare in the United States by state 3075:Thank you for bringing up your concern about the 2054:'s annual roundup of "top contributors" notices. 1038:. The regular SMILES as shown is never changed. 3408:Thank you! Is there anything I can help with? -- 3320:Category:Cannabis in the United States by state 3214:, etc.). Something that reflects the nature of 2571:Knowledge:WikiProject Pharmacology/Participants 1861:Knowledge:WikiProject Pharmacology/Participants 3517:I'm requesting feedback on article content in 3424:Knowledge:WikiProject Pharmacology#How to help 322:Hi. Just to add a little, at FDA, drugs (e.g. 5173:approximates the number of missing pages. -- 4266:approximates the number of missing pages. -- 929:input. JSmol then renders this SMILES string. 3993:Knowledge:Articles for deletion/ATC code A07 3886:Hello all. I've just axed the redirect from 3426:; there's plenty to do on the cleanup list! 1479: 516:Category:Redirects from trade names of drugs 512:, which you created, has been nominated for 358:After re-reading the thread I unarchived at 3918:more than a stub, but not as long as, say, 1412:Thanks (that was quite a typo ... by me!) 828:Criteria for article inclusion in templates 2711:Just 8 in the category now. I'm amazed. 1563:WikiProject collaboration notice from the 1188:Category:Chemical articles having Jmol set 1040:Category:Chemical articles having Jmol set 1030:input for this JSmol image. Example: see 764:I re-nominated this article at FAC today: 437:parameter input. E.g., the USFDA link for 3987:Deletion discussion on the ATC code lists 3523:Talk:Nootropic#Coverage of CNS stimulants 3444:Level of reading for pharmacology content 1517:Radiopharmaceutical article/list overhaul 5806:Thanks a lot! These are very helpful. 5046:example, and pubmed searching, we have: 4899:Thanks a lot! These are very helpful. 4139:example, and pubmed searching, we have: 3685:Enzyme_inhibitor#Irreversible_inhibitors 3631:Enzyme_inhibitor#Irreversible_inhibitors 3350:Never had an account on wikipedia before 3218:in these states, and eventually abroad.ā€• 2848: 1894:Let me know what your thoughts are! (: ā€• 5056:Category:Drugs not assigned an ATC code 4962:Category:Drugs not assigned an ATC code 4149:Category:Drugs not assigned an ATC code 4055:Category:Drugs not assigned an ATC code 2860: 2551:is on the right track with the link to 1594:The discussion about this can be found 1163:, that will categorise the article). - 1080:overwrites the SMILES input for JSmol ( 18:Knowledge talk:WikiProject Pharmacology 14: 3944:list on the pharmacology project list 697:very helpful and very much appreciated 44:Do not edit the contents of this page. 3751:"The taxonomy of Covalent Inhibitors" 3635:"The taxonomy of Covalent Inhibitors" 3041:https://www.drugbank.ca/drugs/DB01198 2904: 1241:for now as I encounter problems. -- 2874: 2872: 2496: 1048:. Already today, one can edit using 25: 5784:https://www.whocc.no/atc_ddd_index/ 4877:https://www.whocc.no/atc_ddd_index/ 925:, the JSmol external link uses the 509:Category:Redirects from trade names 494:Category:Redirects from trade names 23: 4982:. It seems unnecessary to post at 4075:. It seems unnecessary to post at 3798: 1953:I think that's a good suggestion!ā€• 1701:. I suggest getting familiar with 24: 5829: 5760:Wow, I'm impressed by this task! 4853:Wow, I'm impressed by this task! 3607:Awesome. OK, I did that. Thanks. 2232:That seems to be the position of 1078:|Jmol=<SMILES-form string: --> 1020:|Jmol=<SMILES-form string: --> 602:Category:Clinical pharmacologists 589:has been nominated for discussion 587:Category:Clinical pharmacologists 496:has been nominated for discussion 3817:Today's articles for improvement 2905: 2873: 2861: 2849: 2497: 2389:I don't disagree whatsoever--we 2045:current wording and methods but 1634:So far, 84 editors have joined. 1377: 1341: 1011: 1001:(hide) the JSmol link. Example: 940:set, and so have the JSmol link. 682: 644: 593: 500: 124:special:diff/764891086/765098473 103:Drug box 'us-license=' parameter 29: 3720:Irreversible enyzyme inhibitors 3689:Irreversible enyzyme inhibitors 3170:Regulation of therapeutic goods 2640:Removed a few irrelevant tags. 1932:the active list." (or similar) 1064:: The JSmol external link uses 1813:are being used, but we employ 1666:Hello Pharmacology Enthusiasts 1574:Portals are being redesigned. 676:Ī²-Hydroxy Ī²-methylbutyric acid 13: 1: 3707:Irreversible receptor ligands 3521:. The issue is described at 3194:in scope, along the lines of 2345:Knowledge:WikiProject Council 2276:Knowledge:WikiProject Council 1867:Per the policies outlined in 857:13:12, 26 February 2018 (UTC) 637:01:57, 22 December 2017 (UTC) 232:11:52, 30 December 2017 (UTC) 213:11:38, 30 December 2017 (UTC) 162:01:35, 30 December 2017 (UTC) 148:20:24, 29 December 2017 (UTC) 117:17:23, 29 December 2017 (UTC) 5786:, but I think the mirror at 4879:, but I think the mirror at 3666:) 15:54, 25 July 2018 (UTC) 3652:Targeted covalent inhibitors 3467:Featured article review for 2347:; I've started a discussion 1526:List of radiopharmaceuticals 822:03:48, 2 February 2018 (UTC) 790:07:32, 20 January 2018 (UTC) 701:WP:Featured article criteria 662:20:32, 25 January 2018 (UTC) 580:16:29, 18 January 2018 (UTC) 551:16:24, 18 January 2018 (UTC) 7: 3940:Perhaps have a look at the 3894:had already. Yay? I think? 3484:Antioxidant#Drug candidates 3026: 3023: 3020: 3017: 3014: 3011: 3008: 3005: 3002: 2999: 2996: 2993: 2990: 2987: 2984: 2981: 2978: 2975: 2972: 1817:when disagreements occur. ā€• 1186:input lists the article in 759:22:50, 4 January 2018 (UTC) 483:21:57, 4 January 2018 (UTC) 467:21:08, 4 January 2018 (UTC) 420:03:30, 9 January 2018 (UTC) 384:20:55, 4 January 2018 (UTC) 346:12:09, 4 January 2018 (UTC) 318:09:25, 3 January 2018 (UTC) 291:03:34, 3 January 2018 (UTC) 265:03:33, 3 January 2018 (UTC) 10: 5834: 3906:(or vice versa), and from 3845:on behalf of the TAFI team 3843:00:05, 6 August 2018 (UTC) 1879:==] User Activity Update== 1512:14:22, 30 April 2018 (UTC) 1461:13:04, 17 April 2018 (UTC) 1427:13:00, 17 April 2018 (UTC) 1408:12:55, 17 April 2018 (UTC) 1372:07:24, 17 April 2018 (UTC) 1336:07:02, 10 April 2018 (UTC) 1251:12:06, 24 March 2018 (UTC) 1224:19:34, 29 March 2018 (UTC) 1173:17:28, 22 March 2018 (UTC) 1143:14:33, 20 March 2018 (UTC) 1118:14:05, 20 March 2018 (UTC) 1100:14:05, 19 March 2018 (UTC) 902:12:41, 19 March 2018 (UTC) 873:12:50, 19 March 2018 (UTC) 847:or similar older drugs. -- 680: 5816:02:00, 20 June 2020 (UTC) 5800:20:43, 19 June 2020 (UTC) 5755:18:27, 19 June 2020 (UTC) 5183:17:59, 18 June 2020 (UTC) 5152:22:44, 13 June 2020 (UTC) 5126:then jumping a few to ... 5038:17:25, 13 June 2020 (UTC) 4997:21:13, 11 June 2020 (UTC) 4909:02:00, 20 June 2020 (UTC) 4893:20:43, 19 June 2020 (UTC) 4848:18:27, 19 June 2020 (UTC) 4276:17:59, 18 June 2020 (UTC) 4245:22:44, 13 June 2020 (UTC) 4219:then jumping a few to ... 4131:17:25, 13 June 2020 (UTC) 4090:21:13, 11 June 2020 (UTC) 3898:redirect be created from 3824:to appear on Knowledge's 3781:21:47, 26 July 2018 (UTC) 3764:18:16, 25 July 2018 (UTC) 3736:17:12, 25 July 2018 (UTC) 3676:15:55, 25 July 2018 (UTC) 3617:01:39, 17 July 2018 (UTC) 3603:20:40, 16 July 2018 (UTC) 3566:20:56, 15 July 2018 (UTC) 3547:07:52, 13 July 2018 (UTC) 3508:02:19, 11 July 2018 (UTC) 3448:Please see discussion at 3336:18:43, 21 June 2018 (UTC) 3313:18:44, 21 June 2018 (UTC) 3280:00:22, 21 June 2018 (UTC) 3256:21:52, 20 June 2018 (UTC) 3238:02:04, 20 June 2018 (UTC) 3196:Pharmacy laws in Michigan 3186:00:33, 20 June 2018 (UTC) 3156:22:45, 19 June 2018 (UTC) 3122:01:54, 19 June 2018 (UTC) 3107:04:08, 10 June 2018 (UTC) 3062:00:27, 10 June 2018 (UTC) 2838:22:29, 14 June 2018 (UTC) 2785:13:59, 14 June 2018 (UTC) 2771:09:28, 14 June 2018 (UTC) 2752:04:52, 14 June 2018 (UTC) 2721:04:50, 14 June 2018 (UTC) 2621:There are 22 articles at 2597:18:27, 10 June 2018 (UTC) 1852:17:45, 10 June 2018 (UTC) 1837:03:39, 10 June 2018 (UTC) 1794:00:36, 10 June 2018 (UTC) 1767:00:31, 10 June 2018 (UTC) 1751:03:39, 10 June 2018 (UTC) 1309:16:29, 8 April 2018 (UTC) 1289:Dementia with Lewy bodies 1283:01:46, 1 April 2018 (UTC) 1072:hides the external link ( 1012: 993:btw). This can be set to 888:(MW 733) which fails and 617:categories for discussion 531:categories for discussion 443:this FDA drug search page 5764:https://www.drugbank.ca/ 5740:Hello, Iā€™m working with 5166:project-wide spell check 5008:in this scientific paper 4986:each time that happens. 4974:08:48, 8 June 2020 (UTC) 4944:18:34, 7 June 2020 (UTC) 4857:https://www.drugbank.ca/ 4833:Hello, Iā€™m working with 4259:project-wide spell check 4101:in this scientific paper 4079:each time that happens. 4067:08:48, 8 June 2020 (UTC) 4037:18:34, 7 June 2020 (UTC) 4005:16:29, 9 June 2020 (UTC) 3979:08:34, 11 May 2020 (UTC) 3962:08:10, 11 May 2020 (UTC) 3950:Pharmacology Style guide 3935:01:31, 11 May 2020 (UTC) 3716:Irreversible antagonists 3703:Irreversible antagonists 3462:13:26, 9 July 2018 (UTC) 3436:22:36, 4 July 2018 (UTC) 3418:22:08, 4 July 2018 (UTC) 3404:17:23, 4 July 2018 (UTC) 3374:07:06, 4 July 2018 (UTC) 3200:Pharmacy laws in Indiana 2811:WikiProject Pharmacology 2796:WikiProject Pharmacology 2707:03:00, 15 May 2018 (UTC) 2693:02:02, 15 May 2018 (UTC) 2662:00:35, 15 May 2018 (UTC) 2635:23:24, 14 May 2018 (UTC) 2565:23:21, 14 May 2018 (UTC) 2461:current participant page 1719:18:07, 8 June 2018 (UTC) 1691:18:00, 8 June 2018 (UTC) 1661:11:00, 31 May 2018 (UTC) 1557:19:35, 20 May 2018 (UTC) 1542:16:51, 20 May 2018 (UTC) 952:has the same setup: use 3877:09:02, 7 May 2020 (UTC) 3644:Irreversible antagonist 3299:I was more successful. 2617:Experts needed... maybe 2549:Biochemistry & Love 2541:18:40, 7 May 2018 (UTC) 2513:23:58, 6 May 2018 (UTC) 2491:23:06, 6 May 2018 (UTC) 2447:15:17, 5 May 2018 (UTC) 2432:15:02, 5 May 2018 (UTC) 2418:00:46, 4 May 2018 (UTC) 2385:00:26, 4 May 2018 (UTC) 2371:23:56, 3 May 2018 (UTC) 2330:06:09, 3 May 2018 (UTC) 2298:18:53, 2 May 2018 (UTC) 2288:18:18, 2 May 2018 (UTC) 2269:18:10, 2 May 2018 (UTC) 2221:01:48, 2 May 2018 (UTC) 2206:01:28, 2 May 2018 (UTC) 2159:20:48, 1 May 2018 (UTC) 2144:19:28, 1 May 2018 (UTC) 2134:19:12, 1 May 2018 (UTC) 2087:12:59, 1 May 2018 (UTC) 2064:12:54, 1 May 2018 (UTC) 2032:19:28, 1 May 2018 (UTC) 2014:19:12, 1 May 2018 (UTC) 1973:19:12, 1 May 2018 (UTC) 1942:12:04, 1 May 2018 (UTC) 1924:03:57, 1 May 2018 (UTC) 1914:03:21, 1 May 2018 (UTC) 1646:WikiProject's talk page 1617:On April 8th, 2018, an 1586:Transclude lead excerpt 1180:Adding for completeness 5736:Top million substances 5586:List of drugs: Prb-Prn 5502:List of drugs: Mep-Mes 5478:List of drugs: Pro-Prz 5352:List of drugs: Suc-Sul 4829:Top million substances 4679:List of drugs: Prb-Prn 4595:List of drugs: Mep-Mes 4571:List of drugs: Pro-Prz 4445:List of drugs: Suc-Sul 3952:might be helpful too. 3803: 3452:; input very welcome. 3212:Gun laws in New Mexico 1484: 1473:Merger discussion for 733:for that very reason. 406: 295:No I have not (ever). 5616:List of drugs: Sum-Sz 5436:List of drugs: Sp-Sub 5424:List of drugs: Me-Meo 5406:List of drugs: Trj-Tz 5364:List of drugs: Pj-Pra 5268:List of drugs: Tr-Tri 5226:List of drugs: Meu-Mi 4709:List of drugs: Sum-Sz 4529:List of drugs: Sp-Sub 4517:List of drugs: Me-Meo 4499:List of drugs: Trj-Tz 4457:List of drugs: Pj-Pra 4361:List of drugs: Tr-Tri 4319:List of drugs: Meu-Mi 3802: 3712:Irreversible agonists 3699:Irreversible agonists 3583:. I hope that helps!ā€• 3287:Biochemistry&Love 3202:, etc. (analogous to 3164:Biochemistry&Love 2023:Biochemistry&Love 1500:the merger discussion 1483: 398: 42:of past discussions. 5706:List of drugs: Ls-Ly 5700:List of drugs: Rf-Rz 5676:List of drugs: Cf-Ch 5670:List of drugs: Eu-Ex 5664:List of drugs: Mp-My 5658:List of drugs: Pf-Ph 5646:List of drugs: Ad-Ak 5640:List of drugs: Hf-Hz 5634:List of drugs: Eq-Es 5622:List of drugs: Ps-Pz 5610:List of drugs: Tf-Th 5604:List of drugs: Cp-Cz 5574:List of drugs: Aq-Ar 5568:List of drugs: Cm-Co 5562:List of drugs: Dr-Dy 5550:List of drugs: An-Ap 5544:List of drugs: Lf-Ln 5532:List of drugs: Oq-Ow 5496:List of drugs: Nb-Nh 5490:List of drugs: Ia-Il 5484:List of drugs: Nj-Nz 5466:List of drugs: Cb-Ce 5454:List of drugs: Vf-Vz 5442:List of drugs: Iq-Iv 5412:List of drugs: Se-Sh 5394:List of drugs: Bs-Bz 5388:List of drugs: Im-In 5358:List of drugs: As-Az 5334:List of drugs: Ox-Oz 5322:List of drugs: Em-Ep 5310:List of drugs: Bi-Bo 5292:List of drugs: Cj-Cl 5274:List of drugs: Tj-Tq 5262:List of drugs: Sj-So 5250:List of drugs: Fm-Ft 5244:List of drugs: Io-Ip 5220:List of drugs: Pb-Pe 5190:List of drugs: Df-Di 5109:with 45 references; 4799:List of drugs: Ls-Ly 4793:List of drugs: Rf-Rz 4769:List of drugs: Cf-Ch 4763:List of drugs: Eu-Ex 4757:List of drugs: Mp-My 4751:List of drugs: Pf-Ph 4739:List of drugs: Ad-Ak 4733:List of drugs: Hf-Hz 4727:List of drugs: Eq-Es 4715:List of drugs: Ps-Pz 4703:List of drugs: Tf-Th 4697:List of drugs: Cp-Cz 4667:List of drugs: Aq-Ar 4661:List of drugs: Cm-Co 4655:List of drugs: Dr-Dy 4643:List of drugs: An-Ap 4637:List of drugs: Lf-Ln 4625:List of drugs: Oq-Ow 4589:List of drugs: Nb-Nh 4583:List of drugs: Ia-Il 4577:List of drugs: Nj-Nz 4559:List of drugs: Cb-Ce 4547:List of drugs: Vf-Vz 4535:List of drugs: Iq-Iv 4505:List of drugs: Se-Sh 4487:List of drugs: Bs-Bz 4481:List of drugs: Im-In 4451:List of drugs: As-Az 4427:List of drugs: Ox-Oz 4415:List of drugs: Em-Ep 4403:List of drugs: Bi-Bo 4385:List of drugs: Cj-Cl 4367:List of drugs: Tj-Tq 4355:List of drugs: Sj-So 4343:List of drugs: Fm-Ft 4337:List of drugs: Io-Ip 4313:List of drugs: Pb-Pe 4283:List of drugs: Df-Di 4202:with 45 references; 3640:Irreversible agonist 3208:Gun laws in New York 3204:Gun laws in Michigan 981:. There also exists 966:articles, 9800 have 936:articles, 5400 have 706:incredibly difficult 612:the category's entry 533:page. Thank you.. -- 526:the category's entry 298:Infobox drug/licence 5730:List of drugs: A-Ab 5592:List of drugs: M-Md 5556:List of drugs: R-Rb 5520:List of drugs: H-He 5448:List of drugs: D-Dd 5430:List of drugs: E-El 5418:List of drugs: P-Pa 5376:List of drugs: S-Sd 5346:List of drugs: C-Ca 5340:List of drugs: N-Na 5328:List of drugs: V-Ve 5304:List of drugs: O-Op 5298:List of drugs: T-Td 5136:with 254 references 5132:with 2 references; 5119:with 5 references; 5093:with 0 references; 5073:with 0 references; 5050:with 2 references, 4823:List of drugs: A-Ab 4685:List of drugs: M-Md 4649:List of drugs: R-Rb 4613:List of drugs: H-He 4541:List of drugs: D-Dd 4523:List of drugs: E-El 4511:List of drugs: P-Pa 4469:List of drugs: S-Sd 4439:List of drugs: C-Ca 4433:List of drugs: N-Na 4421:List of drugs: V-Ve 4397:List of drugs: O-Op 4391:List of drugs: T-Td 4229:with 254 references 4225:with 2 references; 4212:with 5 references; 4186:with 0 references; 4166:with 0 references; 4143:with 2 references, 1990:(that you can find 1565:Portals WikiProject 1522:Radiopharmaceutical 1214:) work this way. - 652:The CFD was closed 619:page. Thank you. -- 5718:List of drugs: Met 5123:with 19 references 5113:with 45 references 5083:with 1 reference; 5067:with 12 references 5063:with 1 reference; 4811:List of drugs: Met 4216:with 19 references 4206:with 45 references 4176:with 1 reference; 4160:with 12 references 4156:with 1 reference; 3908:ultralente insulin 3820:. The article was 3804: 3648:Suicide inhibition 3172:to what you want? 2456:they actually are? 1639:newsletter archive 1485: 837:Template:Laxatives 5712:List of drugs: Fi 5628:List of drugs: Fa 5598:List of drugs: Do 5580:List of drugs: Ac 5538:List of drugs: La 5526:List of drugs: Be 5514:List of drugs: Lo 5508:List of drugs: Re 5472:List of drugs: Si 5460:List of drugs: Et 5400:List of drugs: Mo 5382:List of drugs: Le 5370:List of drugs: Al 5316:List of drugs: Am 5280:List of drugs: Ni 5256:List of drugs: Fe 5238:List of drugs: Pi 5232:List of drugs: Fl 5214:List of drugs: Ci 5208:List of drugs: De 5202:List of drugs: Te 5196:List of drugs: Ti 4805:List of drugs: Fi 4721:List of drugs: Fa 4691:List of drugs: Do 4673:List of drugs: Ac 4631:List of drugs: La 4619:List of drugs: Be 4607:List of drugs: Lo 4601:List of drugs: Re 4565:List of drugs: Si 4553:List of drugs: Et 4493:List of drugs: Mo 4475:List of drugs: Le 4463:List of drugs: Al 4409:List of drugs: Am 4373:List of drugs: Ni 4349:List of drugs: Fe 4331:List of drugs: Pi 4325:List of drugs: Fl 4307:List of drugs: Ci 4301:List of drugs: De 4295:List of drugs: Te 4289:List of drugs: Ti 3914:(or vice versa)? 3851: 3850: 3808:Please note that 3744:I agree that the 3376: 3360:comment added by 3216:pharmacy practice 3064: 3048:comment added by 3031: 3030: 2112:bang for the buck 1693: 1677:comment added by 1656:TheĀ Transhumanist 1265:420 Collaboration 1259:420 Collaboration 1068:input. Parameter 635: 578: 549: 348: 332:comment added by 215: 199:comment added by 100: 99: 54: 53: 48:current talk page 5825: 5775: 5769: 5724:List of drugs: K 5694:List of drugs: U 5688:List of drugs: X 5682:List of drugs: Q 5652:List of drugs: Z 5286:List of drugs: G 5164:While running a 5035: 5034: 5031: 5028: 5025: 5010:in reference to 4992: 4939: 4868: 4862: 4817:List of drugs: K 4787:List of drugs: U 4781:List of drugs: X 4775:List of drugs: Q 4745:List of drugs: Z 4379:List of drugs: G 4257:While running a 4128: 4127: 4124: 4121: 4118: 4103:in reference to 4085: 4032: 3971: 3841: 3838: 3826:Community portal 3795: 3794: 3746:Enzyme inhibitor 3693:Enzyme inhibitor 3600: 3599: 3596: 3593: 3590: 3577: 3534: 3530: 3513:Feedback request 3495: 3491: 3401: 3400: 3397: 3394: 3391: 3355: 3333: 3328: 3310: 3305: 3290: 3277: 3276: 3273: 3270: 3267: 3244:Drug control law 3235: 3234: 3231: 3228: 3225: 3183: 3178: 3167: 3153: 3152: 3149: 3146: 3143: 3114:CanisLupisArctus 3104: 3103: 3100: 3097: 3094: 3074: 3071:CanisLupisArctus 3050:CanisLupisArctus 3043: 2910: 2909: 2878: 2877: 2876: 2866: 2865: 2854: 2853: 2845: 2844: 2825: 2821: 2814: 2803:rating parameter 2802: 2799: 2690: 2689: 2686: 2683: 2680: 2672: 2649: 2645: 2594: 2593: 2590: 2587: 2584: 2538: 2537: 2534: 2531: 2528: 2502: 2501: 2500: 2488: 2487: 2484: 2481: 2478: 2415: 2414: 2411: 2408: 2405: 2368: 2367: 2364: 2361: 2358: 2341: 2266: 2265: 2262: 2259: 2256: 2231: 2203: 2202: 2199: 2196: 2193: 2184: 2169: 2131: 2130: 2127: 2124: 2121: 2097: 2026: 2011: 2010: 2007: 2004: 2001: 1985: 1970: 1969: 1966: 1963: 1960: 1952: 1911: 1910: 1907: 1904: 1901: 1863:Activity Updates 1834: 1833: 1830: 1827: 1824: 1811:reliable sources 1804: 1801:CanisLupisArctus 1781: 1777: 1759:CanisLupisArctus 1748: 1747: 1744: 1741: 1738: 1729: 1672: 1659: 1590: 1584: 1448: 1444: 1438: 1419: 1395: 1391: 1385: 1381: 1380: 1359: 1355: 1345: 1323: 1319: 1301: 1278: 1271: 1270:Another Believer 1240: 1236: 1213: 1209: 1203: 1199: 1193: 1185: 1162: 1129: 1088: 1079: 1071: 1067: 1051: 1037: 1029: 1021: 1017: 1016: 1015: 1014: 996: 992: 984: 980: 969: 965: 962: 961: 955: 951: 945: 939: 935: 928: 924: 918: 879:3D model (JSmol) 809: 805: 777: 773: 746: 742: 725:. For instance, 686: 685: 648: 626: 623: 597: 596: 569: 566: 540: 537: 504: 503: 454: 450: 436: 432: 394: 371: 367: 357: 327: 300: 278: 274: 252: 248: 242: 194: 135: 131: 81: 56: 55: 33: 32: 26: 5833: 5832: 5828: 5827: 5826: 5824: 5823: 5822: 5773: 5767: 5738: 5162: 5032: 5029: 5026: 5021: 5020: 4988: 4954:GlaxoSmithKline 4935: 4919: 4866: 4860: 4831: 4255: 4125: 4122: 4119: 4114: 4113: 4081: 4047:GlaxoSmithKline 4028: 4012: 3989: 3884: 3882:A few questions 3856: 3846: 3836: 3832: 3793: 3646:, and articles 3627: 3597: 3594: 3591: 3586: 3585: 3571: 3554: 3532: 3528: 3515: 3493: 3489: 3472: 3446: 3398: 3395: 3392: 3387: 3386: 3352: 3331: 3324: 3308: 3301: 3284: 3274: 3271: 3268: 3263: 3262: 3246:and elsewhere. 3232: 3229: 3226: 3221: 3220: 3181: 3174: 3161: 3150: 3147: 3144: 3139: 3138: 3129: 3101: 3098: 3095: 3090: 3089: 3068: 3036: 2823: 2819: 2808: 2805: 2800: 2793: 2757:Found at least 2733: 2687: 2684: 2681: 2676: 2675: 2666: 2647: 2643: 2619: 2591: 2588: 2585: 2580: 2579: 2535: 2532: 2529: 2524: 2523: 2498: 2485: 2482: 2479: 2474: 2473: 2412: 2409: 2406: 2401: 2400: 2365: 2362: 2359: 2354: 2353: 2335: 2263: 2260: 2257: 2252: 2251: 2225: 2200: 2197: 2194: 2189: 2188: 2178: 2163: 2128: 2125: 2122: 2117: 2116: 2091: 2020: 2008: 2005: 2002: 1997: 1996: 1979: 1967: 1964: 1961: 1956: 1955: 1946: 1908: 1905: 1902: 1897: 1896: 1865: 1831: 1828: 1825: 1820: 1819: 1798: 1779: 1775: 1745: 1742: 1739: 1734: 1733: 1723: 1668: 1652: 1615: 1588: 1582: 1568: 1519: 1478: 1446: 1442: 1432: 1417: 1393: 1389: 1378: 1376: 1357: 1353: 1321: 1317: 1299: 1292: 1281: 1276: 1269: 1261: 1238: 1230: 1211: 1207: 1201: 1197: 1191: 1183: 1160: 1127: 1086: 1077: 1069: 1065: 1049: 1035: 1027: 1019: 1010: 1008: 994: 986: 982: 974: 967: 963: 959: 957: 953: 949: 943: 937: 933: 926: 922: 916: 881: 830: 807: 803: 775: 771: 744: 740: 689: 688: 683: 679: 659: 621: 598: 594: 591: 564: 535: 505: 501: 498: 452: 448: 434: 426: 388: 369: 365: 351: 296: 276: 272: 250: 246: 236: 133: 129: 105: 77: 30: 22: 21: 20: 12: 11: 5: 5831: 5821: 5820: 5819: 5818: 5803: 5802: 5777: 5737: 5734: 5733: 5732: 5726: 5720: 5714: 5708: 5702: 5696: 5690: 5684: 5678: 5672: 5666: 5660: 5654: 5648: 5642: 5636: 5630: 5624: 5618: 5612: 5606: 5600: 5594: 5588: 5582: 5576: 5570: 5564: 5558: 5552: 5546: 5540: 5534: 5528: 5522: 5516: 5510: 5504: 5498: 5492: 5486: 5480: 5474: 5468: 5462: 5456: 5450: 5444: 5438: 5432: 5426: 5420: 5414: 5408: 5402: 5396: 5390: 5384: 5378: 5372: 5366: 5360: 5354: 5348: 5342: 5336: 5330: 5324: 5318: 5312: 5306: 5300: 5294: 5288: 5282: 5276: 5270: 5264: 5258: 5252: 5246: 5240: 5234: 5228: 5222: 5216: 5210: 5204: 5198: 5192: 5161: 5158: 5157: 5156: 5155: 5154: 5139: 5138: 5137: 5127: 5124: 5114: 5104: 5098: 5088: 5078: 5068: 5001: 5000: 4999: 4918: 4915: 4914: 4913: 4912: 4911: 4896: 4895: 4870: 4830: 4827: 4826: 4825: 4819: 4813: 4807: 4801: 4795: 4789: 4783: 4777: 4771: 4765: 4759: 4753: 4747: 4741: 4735: 4729: 4723: 4717: 4711: 4705: 4699: 4693: 4687: 4681: 4675: 4669: 4663: 4657: 4651: 4645: 4639: 4633: 4627: 4621: 4615: 4609: 4603: 4597: 4591: 4585: 4579: 4573: 4567: 4561: 4555: 4549: 4543: 4537: 4531: 4525: 4519: 4513: 4507: 4501: 4495: 4489: 4483: 4477: 4471: 4465: 4459: 4453: 4447: 4441: 4435: 4429: 4423: 4417: 4411: 4405: 4399: 4393: 4387: 4381: 4375: 4369: 4363: 4357: 4351: 4345: 4339: 4333: 4327: 4321: 4315: 4309: 4303: 4297: 4291: 4285: 4254: 4251: 4250: 4249: 4248: 4247: 4232: 4231: 4230: 4220: 4217: 4207: 4197: 4191: 4181: 4171: 4161: 4094: 4093: 4092: 4011: 4008: 3988: 3985: 3984: 3983: 3982: 3981: 3883: 3880: 3869:Project Osprey 3855: 3852: 3849: 3848: 3830: 3829: 3807: 3792: 3789: 3788: 3787: 3786: 3785: 3784: 3783: 3739: 3738: 3725: 3724: 3723: 3709: 3696: 3626: 3623: 3622: 3621: 3620: 3619: 3553: 3550: 3514: 3511: 3471: 3465: 3445: 3442: 3441: 3440: 3439: 3438: 3406: 3384:and dive in! ā€• 3351: 3348: 3347: 3346: 3345: 3344: 3343: 3342: 3341: 3340: 3339: 3338: 3326:Blue Rasberry 3315: 3303:Blue Rasberry 3176:Blue Rasberry 3128: 3125: 3110: 3109: 3035: 3032: 3029: 3028: 3025: 3022: 3019: 3016: 3013: 3010: 3007: 3004: 3001: 2998: 2995: 2992: 2989: 2986: 2983: 2980: 2977: 2974: 2970: 2969: 2964: 2959: 2954: 2949: 2944: 2939: 2934: 2929: 2924: 2919: 2914: 2902: 2897: 2892: 2887: 2882: 2870: 2858: 2842: 2804: 2791: 2790: 2789: 2788: 2787: 2740:Drug titration 2736:User:Natureium 2732: 2731:Dose titration 2729: 2728: 2727: 2726: 2725: 2724: 2723: 2664: 2618: 2615: 2614: 2613: 2612: 2611: 2610: 2609: 2608: 2607: 2606: 2605: 2604: 2603: 2602: 2601: 2600: 2599: 2545: 2544: 2543: 2465:more stringent 2457: 2317: 2316: 2315: 2314: 2313: 2312: 2311: 2310: 2309: 2308: 2307: 2306: 2305: 2304: 2303: 2302: 2301: 2300: 2290: 2176: 2100: 2099:participants?" 2040: 2039: 2038: 2037: 2036: 2035: 2034: 1977: 1976: 1975: 1888: 1887: 1880: 1864: 1858: 1857: 1856: 1855: 1854: 1796: 1754: 1753: 1721: 1667: 1664: 1614: 1611: 1567: 1561: 1560: 1559: 1518: 1515: 1477: 1471: 1470: 1469: 1468: 1467: 1466: 1465: 1464: 1463: 1347:Pending action 1338: 1291: 1286: 1273: 1260: 1257: 1256: 1255: 1254: 1253: 1228: 1227: 1226: 1190:(34). 6. both 1149: 1148: 1147: 1146: 1145: 1131: 1103: 1102: 1058: 1057: 1043: 1022:, This way it 1018:). Or used as 971: 941: 930: 912: 911: 880: 877: 876: 875: 829: 826: 825: 824: 793: 792: 695:ā€“ it would be 681: 678: 674:nomination of 668: 667: 666: 665: 664: 657: 607:categorization 592: 590: 584: 583: 582: 521:categorization 499: 497: 491: 490: 489: 488: 487: 486: 485: 471: 470: 469: 424: 423: 422: 407: 402: 401: 396: 320: 306: 302: 267: 187: 186: 185: 184: 183: 182: 176: 167: 104: 101: 98: 97: 92: 87: 82: 75: 70: 65: 62: 52: 51: 34: 15: 9: 6: 4: 3: 2: 5830: 5817: 5813: 5809: 5805: 5804: 5801: 5797: 5793: 5789: 5785: 5781: 5778: 5772: 5765: 5762: 5761: 5759: 5758: 5757: 5756: 5752: 5748: 5743: 5731: 5727: 5725: 5721: 5719: 5715: 5713: 5709: 5707: 5703: 5701: 5697: 5695: 5691: 5689: 5685: 5683: 5679: 5677: 5673: 5671: 5667: 5665: 5661: 5659: 5655: 5653: 5649: 5647: 5643: 5641: 5637: 5635: 5631: 5629: 5625: 5623: 5619: 5617: 5613: 5611: 5607: 5605: 5601: 5599: 5595: 5593: 5589: 5587: 5583: 5581: 5577: 5575: 5571: 5569: 5565: 5563: 5559: 5557: 5553: 5551: 5547: 5545: 5541: 5539: 5535: 5533: 5529: 5527: 5523: 5521: 5517: 5515: 5511: 5509: 5505: 5503: 5499: 5497: 5493: 5491: 5487: 5485: 5481: 5479: 5475: 5473: 5469: 5467: 5463: 5461: 5457: 5455: 5451: 5449: 5445: 5443: 5439: 5437: 5433: 5431: 5427: 5425: 5421: 5419: 5415: 5413: 5409: 5407: 5403: 5401: 5397: 5395: 5391: 5389: 5385: 5383: 5379: 5377: 5373: 5371: 5367: 5365: 5361: 5359: 5355: 5353: 5349: 5347: 5343: 5341: 5337: 5335: 5331: 5329: 5325: 5323: 5319: 5317: 5313: 5311: 5307: 5305: 5301: 5299: 5295: 5293: 5289: 5287: 5283: 5281: 5277: 5275: 5271: 5269: 5265: 5263: 5259: 5257: 5253: 5251: 5247: 5245: 5241: 5239: 5235: 5233: 5229: 5227: 5223: 5221: 5217: 5215: 5211: 5209: 5205: 5203: 5199: 5197: 5193: 5191: 5187: 5186: 5185: 5184: 5180: 5176: 5171: 5170:List of drugs 5167: 5160:Missing drugs 5153: 5149: 5145: 5140: 5135: 5131: 5128: 5125: 5122: 5118: 5115: 5112: 5108: 5105: 5102: 5099: 5096: 5092: 5089: 5086: 5082: 5079: 5076: 5072: 5069: 5066: 5062: 5059: 5058: 5057: 5053: 5049: 5045: 5041: 5040: 5039: 5036: 5024: 5017: 5013: 5009: 5005: 5002: 4998: 4995: 4993: 4991: 4985: 4981: 4977: 4976: 4975: 4971: 4967: 4963: 4959: 4955: 4951: 4948: 4947: 4946: 4945: 4942: 4940: 4938: 4932: 4928: 4924: 4917:Company codes 4910: 4906: 4902: 4898: 4897: 4894: 4890: 4886: 4882: 4878: 4874: 4871: 4865: 4858: 4855: 4854: 4852: 4851: 4850: 4849: 4845: 4841: 4836: 4824: 4820: 4818: 4814: 4812: 4808: 4806: 4802: 4800: 4796: 4794: 4790: 4788: 4784: 4782: 4778: 4776: 4772: 4770: 4766: 4764: 4760: 4758: 4754: 4752: 4748: 4746: 4742: 4740: 4736: 4734: 4730: 4728: 4724: 4722: 4718: 4716: 4712: 4710: 4706: 4704: 4700: 4698: 4694: 4692: 4688: 4686: 4682: 4680: 4676: 4674: 4670: 4668: 4664: 4662: 4658: 4656: 4652: 4650: 4646: 4644: 4640: 4638: 4634: 4632: 4628: 4626: 4622: 4620: 4616: 4614: 4610: 4608: 4604: 4602: 4598: 4596: 4592: 4590: 4586: 4584: 4580: 4578: 4574: 4572: 4568: 4566: 4562: 4560: 4556: 4554: 4550: 4548: 4544: 4542: 4538: 4536: 4532: 4530: 4526: 4524: 4520: 4518: 4514: 4512: 4508: 4506: 4502: 4500: 4496: 4494: 4490: 4488: 4484: 4482: 4478: 4476: 4472: 4470: 4466: 4464: 4460: 4458: 4454: 4452: 4448: 4446: 4442: 4440: 4436: 4434: 4430: 4428: 4424: 4422: 4418: 4416: 4412: 4410: 4406: 4404: 4400: 4398: 4394: 4392: 4388: 4386: 4382: 4380: 4376: 4374: 4370: 4368: 4364: 4362: 4358: 4356: 4352: 4350: 4346: 4344: 4340: 4338: 4334: 4332: 4328: 4326: 4322: 4320: 4316: 4314: 4310: 4308: 4304: 4302: 4298: 4296: 4292: 4290: 4286: 4284: 4280: 4279: 4278: 4277: 4273: 4269: 4264: 4263:List of drugs 4260: 4253:Missing drugs 4246: 4242: 4238: 4233: 4228: 4224: 4221: 4218: 4215: 4211: 4208: 4205: 4201: 4198: 4195: 4192: 4189: 4185: 4182: 4179: 4175: 4172: 4169: 4165: 4162: 4159: 4155: 4152: 4151: 4150: 4146: 4142: 4138: 4134: 4133: 4132: 4129: 4117: 4110: 4106: 4102: 4098: 4095: 4091: 4088: 4086: 4084: 4078: 4074: 4070: 4069: 4068: 4064: 4060: 4056: 4052: 4048: 4044: 4041: 4040: 4039: 4038: 4035: 4033: 4031: 4025: 4021: 4017: 4010:Company codes 4007: 4006: 4002: 3998: 3994: 3980: 3976: 3972: 3965: 3964: 3963: 3959: 3955: 3951: 3947: 3943: 3939: 3938: 3937: 3936: 3932: 3928: 3923: 3921: 3915: 3913: 3909: 3905: 3904:lente insulin 3901: 3895: 3893: 3889: 3888:lente insulin 3879: 3878: 3874: 3870: 3866: 3861: 3847: 3844: 3840: 3839: 3831:Delivered by 3827: 3823: 3819: 3818: 3813: 3812: 3801: 3797: 3796: 3782: 3778: 3774: 3770: 3767: 3766: 3765: 3761: 3757: 3752: 3747: 3743: 3742: 3741: 3740: 3737: 3733: 3729: 3726: 3721: 3717: 3713: 3710: 3708: 3704: 3700: 3697: 3694: 3690: 3686: 3683: 3682: 3680: 3679: 3678: 3677: 3673: 3669: 3665: 3661: 3657: 3653: 3649: 3645: 3641: 3636: 3632: 3618: 3614: 3610: 3606: 3605: 3604: 3601: 3589: 3582: 3575: 3570: 3569: 3568: 3567: 3563: 3559: 3549: 3548: 3544: 3543: 3537: 3536: 3535: 3524: 3520: 3510: 3509: 3505: 3504: 3498: 3497: 3496: 3485: 3481: 3477: 3470: 3464: 3463: 3459: 3455: 3451: 3437: 3433: 3429: 3425: 3421: 3420: 3419: 3415: 3411: 3407: 3405: 3402: 3390: 3383: 3379: 3378: 3377: 3375: 3371: 3367: 3363: 3359: 3337: 3334: 3329: 3327: 3321: 3316: 3314: 3311: 3306: 3304: 3298: 3294: 3288: 3283: 3282: 3281: 3278: 3266: 3259: 3258: 3257: 3253: 3249: 3245: 3241: 3240: 3239: 3236: 3224: 3217: 3213: 3209: 3205: 3201: 3197: 3193: 3189: 3188: 3187: 3184: 3179: 3177: 3171: 3168:How close is 3165: 3160: 3159: 3158: 3157: 3154: 3142: 3135: 3134:Knowledge:Law 3124: 3123: 3119: 3115: 3108: 3105: 3093: 3086: 3082: 3078: 3072: 3067: 3066: 3065: 3063: 3059: 3055: 3051: 3047: 3042: 3034:Zaleplon Page 2971: 2968: 2965: 2963: 2960: 2958: 2955: 2953: 2950: 2948: 2945: 2943: 2940: 2938: 2935: 2933: 2930: 2928: 2925: 2923: 2920: 2918: 2915: 2913: 2908: 2903: 2901: 2898: 2896: 2893: 2891: 2888: 2886: 2883: 2881: 2871: 2869: 2864: 2859: 2857: 2852: 2847: 2846: 2843: 2840: 2839: 2835: 2834: 2828: 2827: 2826: 2812: 2797: 2786: 2782: 2778: 2774: 2773: 2772: 2768: 2764: 2760: 2756: 2755: 2754: 2753: 2749: 2745: 2741: 2737: 2722: 2718: 2714: 2710: 2709: 2708: 2704: 2700: 2696: 2695: 2694: 2691: 2679: 2670: 2665: 2663: 2659: 2658: 2652: 2651: 2650: 2639: 2638: 2637: 2636: 2632: 2628: 2624: 2598: 2595: 2583: 2576: 2572: 2568: 2567: 2566: 2562: 2558: 2554: 2550: 2547:I think that 2546: 2542: 2539: 2527: 2520: 2516: 2515: 2514: 2510: 2506: 2494: 2493: 2492: 2489: 2477: 2470: 2466: 2463:; it is even 2462: 2458: 2455: 2450: 2449: 2448: 2444: 2440: 2435: 2434: 2433: 2429: 2425: 2421: 2420: 2419: 2416: 2404: 2397: 2392: 2388: 2387: 2386: 2382: 2378: 2374: 2373: 2372: 2369: 2357: 2350: 2346: 2339: 2334: 2333: 2332: 2331: 2327: 2323: 2299: 2296: 2295:Dirk Beetstra 2291: 2289: 2285: 2281: 2277: 2272: 2271: 2270: 2267: 2255: 2247: 2243: 2239: 2235: 2229: 2224: 2223: 2222: 2218: 2214: 2209: 2208: 2207: 2204: 2192: 2182: 2177: 2174: 2167: 2162: 2161: 2160: 2156: 2152: 2147: 2146: 2145: 2142: 2141:Dirk Beetstra 2137: 2136: 2135: 2132: 2120: 2113: 2109: 2105: 2101: 2095: 2090: 2089: 2088: 2084: 2080: 2076: 2071: 2067: 2066: 2065: 2061: 2057: 2053: 2048: 2044: 2041: 2033: 2030: 2029:Dirk Beetstra 2024: 2019: 2018: 2017: 2016: 2015: 2012: 2000: 1993: 1989: 1983: 1978: 1974: 1971: 1959: 1950: 1945: 1944: 1943: 1939: 1935: 1930: 1927: 1926: 1925: 1922: 1921:Dirk Beetstra 1918: 1917: 1916: 1915: 1912: 1900: 1892: 1885: 1881: 1878: 1877: 1876: 1874: 1870: 1862: 1853: 1849: 1845: 1840: 1839: 1838: 1835: 1823: 1816: 1812: 1808: 1802: 1797: 1795: 1791: 1790: 1784: 1783: 1782: 1771: 1770: 1769: 1768: 1764: 1760: 1752: 1749: 1737: 1727: 1722: 1720: 1716: 1712: 1708: 1704: 1700: 1696: 1695: 1694: 1692: 1688: 1684: 1680: 1676: 1663: 1662: 1658: 1657: 1649: 1647: 1642: 1640: 1635: 1632: 1629: 1627: 1622: 1620: 1610: 1608: 1607: 1601: 1599: 1598: 1592: 1587: 1578: 1575: 1572: 1566: 1558: 1554: 1550: 1546: 1545: 1544: 1543: 1539: 1535: 1531: 1527: 1523: 1514: 1513: 1509: 1505: 1502:. Thank you. 1501: 1497: 1496: 1493:proposed for 1490: 1482: 1476: 1462: 1458: 1457: 1451: 1450: 1449: 1436: 1430: 1429: 1428: 1424: 1420: 1416: 1411: 1410: 1409: 1405: 1404: 1398: 1397: 1396: 1384: 1375: 1374: 1373: 1369: 1368: 1362: 1361: 1360: 1349: 1348: 1344: 1339: 1337: 1333: 1332: 1326: 1325: 1324: 1313: 1312: 1311: 1310: 1306: 1302: 1298: 1290: 1285: 1284: 1279: 1272: 1266: 1252: 1248: 1244: 1234: 1229: 1225: 1221: 1217: 1206: 1196: 1189: 1181: 1178: 1177: 1176: 1175: 1174: 1170: 1166: 1158: 1154: 1150: 1144: 1140: 1136: 1132: 1130:for tracking. 1125: 1121: 1120: 1119: 1115: 1111: 1107: 1106: 1105: 1104: 1101: 1097: 1093: 1089: 1083: 1075: 1063: 1060: 1059: 1055: 1054:automatically 1047: 1044: 1041: 1033: 1026:the original 1025: 1006: 1004: 1000: 990: 978: 972: 948: 942: 931: 921: 914: 913: 909: 906: 905: 904: 903: 899: 895: 891: 887: 874: 870: 866: 861: 860: 859: 858: 854: 850: 846: 842: 838: 835:For example, 833: 823: 819: 818: 812: 811: 810: 799: 795: 794: 791: 787: 786: 780: 779: 778: 767: 763: 762: 761: 760: 756: 755: 749: 748: 747: 734: 732: 728: 724: 722: 718: 714: 708: 707: 702: 698: 694: 677: 673: 663: 660: 655: 651: 647: 643: 642: 641: 640: 639: 638: 633: 629: 625: 618: 614: 613: 608: 604: 603: 588: 581: 576: 572: 568: 561: 558: 555: 554: 553: 552: 547: 543: 539: 532: 528: 527: 522: 518: 517: 511: 510: 495: 484: 480: 476: 472: 468: 464: 463: 457: 456: 455: 444: 440: 430: 425: 421: 417: 413: 408: 405: 397: 392: 387: 386: 385: 381: 380: 374: 373: 372: 361: 355: 350: 349: 347: 343: 339: 335: 331: 325: 321: 319: 315: 311: 307: 303: 299: 294: 293: 292: 288: 287: 281: 280: 279: 268: 266: 262: 261: 255: 254: 253: 240: 235: 234: 233: 229: 225: 221: 218: 217: 216: 214: 210: 206: 202: 198: 191: 180: 179:Acalabrutinib 177: 175: 171: 168: 165: 164: 163: 159: 155: 151: 150: 149: 145: 144: 138: 137: 136: 125: 121: 120: 119: 118: 114: 110: 96: 93: 91: 88: 86: 83: 80: 76: 74: 71: 69: 66: 63: 61: 58: 57: 49: 45: 41: 40: 35: 28: 27: 19: 5771:Infobox drug 5739: 5163: 5133: 5120: 5110: 5094: 5084: 5074: 5064: 5051: 5047: 5042:Taking that 5022: 5003: 4989: 4949: 4936: 4920: 4864:Infobox drug 4832: 4256: 4226: 4213: 4203: 4187: 4177: 4167: 4157: 4144: 4140: 4135:Taking that 4115: 4096: 4082: 4042: 4029: 4013: 3990: 3970:bɜ:Ź³kənhÉŖmez 3941: 3927:Berchanhimez 3924: 3916: 3896: 3885: 3858:An apparent 3857: 3834: 3815: 3809: 3805: 3768: 3658:as a guide. 3628: 3587: 3555: 3541: 3531: 3527: 3516: 3502: 3492: 3488: 3473: 3447: 3388: 3356:ā€”Ā Preceding 3353: 3325: 3302: 3264: 3222: 3191: 3175: 3140: 3130: 3127:Pharmacy law 3111: 3091: 3044:ā€”Ā Preceding 3037: 2841: 2832: 2822: 2818: 2806: 2744:WhatamIdoing 2734: 2713:WhatamIdoing 2699:WhatamIdoing 2677: 2669:WhatamIdoing 2656: 2646: 2642: 2627:WhatamIdoing 2620: 2581: 2557:WhatamIdoing 2525: 2475: 2464: 2453: 2402: 2390: 2355: 2318: 2253: 2190: 2172: 2118: 2103: 2075:in the field 2074: 2069: 2046: 2042: 1998: 1957: 1928: 1898: 1893: 1889: 1866: 1821: 1788: 1778: 1774: 1755: 1735: 1673:ā€”Ā Preceding 1669: 1654: 1651:Thank you. 1650: 1643: 1636: 1633: 1630: 1623: 1616: 1604: 1602: 1595: 1593: 1579: 1576: 1573: 1569: 1520: 1492: 1486: 1455: 1445: 1441: 1414: 1402: 1392: 1388: 1382: 1366: 1356: 1352: 1346: 1340: 1330: 1320: 1316: 1296: 1293: 1262: 1205:Infobox drug 1179: 1152: 1124:erythromicin 1085: 1061: 1053: 1045: 1023: 998: 988: 976: 932:In the 6500 907: 886:erythromicin 882: 834: 831: 816: 806: 802: 784: 774: 770: 753: 743: 739: 735: 710: 705: 704: 696: 690: 649: 610: 600: 599: 556: 524: 514:renaming to 513: 507: 506: 461: 451: 447: 435:|licence_US= 399: 378: 368: 364: 328:ā€”Ā Preceding 285: 275: 271: 259: 249: 245: 195:ā€”Ā Preceding 188: 142: 132: 128: 106: 78: 43: 37: 5101:GSK-789,472 5091:EGIS-12,233 5004:Weak oppose 4194:GSK-789,472 4184:EGIS-12,233 4097:Weak oppose 3920:NPH insulin 3687:ā†’ expanded 3469:Antioxidant 2139:a month. ā€” 2050:Compare to 1703:WP:PHARMMOS 1624:There's an 1212:{{Drugbox}} 1087:{{Chembox}} 1036:{{Chembox}} 1007:(edited by 964:{{Chembox}} 934:{{Drugbox}} 890:simvastatin 727:amphetamine 439:amphetamine 36:This is an 5792:į¼€Ī½Ļ…Ļ€ĻŒĪ“Ī·Ļ„ĪæĻ‚ 5742:User:Egonw 5130:SKF-81,297 5117:LY-487,379 5095:EGIS-12233 5071:BRL-15,572 5061:AR-231,453 5048:SKF-81,297 5044:SKF-81,297 5012:SKF-81,297 4980:SKF-81,297 4931:GR-196,429 4885:į¼€Ī½Ļ…Ļ€ĻŒĪ“Ī·Ļ„ĪæĻ‚ 4835:User:Egonw 4223:SKF-81,297 4210:LY-487,379 4188:EGIS-12233 4164:BRL-15,572 4154:AR-231,453 4141:SKF-81,297 4137:SKF-81,297 4105:SKF-81,297 4073:SKF-81,297 4024:GR-196,429 3997:į¼€Ī½Ļ…Ļ€ĻŒĪ“Ī·Ļ„ĪæĻ‚ 3912:ultralente 3892:ultralente 3656:WP:Merging 2521:then.. šŸ˜…ā€• 2505:Tryptofish 2439:Tryptofish 2377:Tryptofish 2338:Tryptofish 2280:Tryptofish 2228:Tryptofish 2213:Tryptofish 2181:Tryptofish 2151:Tryptofish 2104:especially 2047:no opinion 1844:Tryptofish 1726:RosalindPK 1711:Tryptofish 1679:RosalindPK 1613:Background 1549:Tryptofish 1504:SusanLesch 1491:ā€”has been 1489:Vitamin B3 1475:Vitamin B3 1239:|Jmol=none 1128:|Jmol=none 1070:|Jmol=none 1024:overwrites 1003:Mipomersen 995:|Jmol=none 973:Parameter 908:Background 624:HairedGirl 567:HairedGirl 538:HairedGirl 475:Wowbagger2 429:Wowbagger2 334:Wowbagger2 324:Idelalisib 305:possible). 201:Wowbagger2 170:Copanlisib 109:Wowbagger2 95:ArchiveĀ 17 90:ArchiveĀ 16 85:ArchiveĀ 15 79:ArchiveĀ 14 73:ArchiveĀ 13 68:ArchiveĀ 12 60:ArchiveĀ 10 5780:ATC codes 5134:SKF-81297 5121:LY-487379 5107:L-368,899 5081:CP-39,332 5075:BRL-15572 5065:AR-231453 5052:SKF-81297 5027:chemistry 4958:GR-127935 4873:ATC codes 4227:SKF-81297 4214:LY-487379 4200:L-368,899 4174:CP-39,332 4168:BRL-15572 4158:AR-231453 4145:SKF-81297 4120:chemistry 4051:GR-127935 3822:scheduled 3811:Club drug 3592:chemistry 3519:nootropic 3410:Chemotron 3393:chemistry 3362:Chemotron 3269:chemistry 3227:chemistry 3145:chemistry 3096:chemistry 3081:selective 2777:Natureium 2682:chemistry 2586:chemistry 2530:chemistry 2480:chemistry 2407:chemistry 2396:Red Cross 2360:chemistry 2258:chemistry 2195:chemistry 2123:chemistry 2003:chemistry 1988:Skittleys 1962:chemistry 1903:chemistry 1869:this page 1826:chemistry 1815:consensus 1740:chemistry 1699:WP:BEBOLD 1435:TOC limit 1182:: 5. Any 1157:Ferrocene 1032:Ferrocene 703:. It is 473:I agree! 5808:Walkerma 5747:Walkerma 5111:L-368899 5085:CP-39332 4984:WP:RM#TM 4923:AGN-2979 4901:Walkerma 4840:Walkerma 4204:L-368899 4178:CP-39332 4077:WP:RM#TM 4016:AGN-2979 3865:WP:MEDRS 3837:MusikBot 3609:T0mpr1c3 3574:T0mpr1c3 3558:T0mpr1c3 3552:Vaccines 3370:contribs 3358:unsigned 3077:zaleplon 3058:contribs 3046:unsigned 2957:Template 2952:Redirect 2927:Disambig 2922:Category 2775:Thanks! 2238:Beetstra 2166:Beetstra 1982:Beetstra 1873:Beetstra 1707:WP:MEDRS 1687:contribs 1675:unsigned 1247:Edgar181 1066:|SMILES= 1028:|SMILES= 999:suppress 968:|SMILES= 954:|SMILES= 938:|SMILES= 927:|SMILES= 898:Edgar181 869:Edgar181 717:WP:PHARM 687:Resolved 632:contribs 575:contribs 557:See also 546:contribs 412:Garzfoth 391:Seppi333 354:Garzfoth 342:contribs 330:unsigned 209:contribs 197:unsigned 5144:Klbrain 5077:with 14 5016:AMG 319 4990:Bait30 4966:Klbrain 4950:Support 4937:Bait30 4927:GNF6702 4237:Klbrain 4170:with 14 4109:AMG 319 4083:Bait30 4059:Klbrain 4043:Support 4030:Bait30 4020:GNF6702 3975:say hi! 3954:Klbrain 3942:Class C 3860:styrene 3854:Styrene 3756:Jlf3756 3668:Jlf3756 3660:Jlf3756 3540:Insert 3501:Insert 3428:Klbrain 3382:WP:BOLD 3248:Klbrain 2947:Project 2831:Insert 2801:|class= 2655:Insert 2246:WP:CHEM 2068:I also 1949:Klbrain 1934:Klbrain 1929:Support 1807:WP:BOLD 1787:Insert 1495:merging 1454:Insert 1418:Georgia 1401:Insert 1365:Insert 1329:Insert 1300:Georgia 1195:Chembox 1082:example 1076:), and 1074:example 1046:Options 947:Chembox 920:Drugbox 841:Linseed 815:Insert 783:Insert 752:Insert 615:on the 529:on the 460:Insert 377:Insert 284:Insert 258:Insert 141:Insert 39:archive 5175:Beland 5097:with 1 5087:with 0 4268:Beland 4190:with 1 4180:with 0 3806:Hello, 3773:Boghog 3728:Boghog 3476:WP:MCB 3454:Jytdog 3332:(talk) 3309:(talk) 3192:narrow 3182:(talk) 2942:Portal 2763:Boghog 2454:active 2424:DMacks 2391:should 2322:DMacks 2249:well?ā€• 2242:WP:MED 2234:DMacks 2094:DMacks 2079:DMacks 2070:oppose 2056:DMacks 2052:WP:MED 2043:Oppose 1534:DMacks 1233:DePiep 1216:DePiep 1184:|Jmol= 1165:DePiep 1161:|Jmol= 1153:broken 1135:DePiep 1110:Jytdog 1092:DePiep 1050:|Jmol= 1009:Jytdog 983:|Jmol= 839:links 721:WP:MCB 713:WP:MED 672:WP:FAC 628:(talk) 571:(talk) 542:(talk) 310:DePiep 239:DePiep 224:DePiep 154:DePiep 5578:10 - 5572:10 - 5566:11 - 5560:11 - 5554:11 - 5548:12 - 5542:12 - 5536:13 - 5530:13 - 5524:14 - 5518:14 - 5512:15 - 5506:15 - 5500:17 - 5494:17 - 5488:18 - 5482:18 - 5476:18 - 5470:18 - 5464:19 - 5458:19 - 5452:19 - 5446:20 - 5440:20 - 5434:20 - 5428:21 - 5422:21 - 5416:21 - 5410:21 - 5404:21 - 5398:22 - 5392:23 - 5386:23 - 5380:24 - 5374:24 - 5368:25 - 5362:25 - 5356:27 - 5350:27 - 5344:28 - 5338:28 - 5332:28 - 5326:28 - 5320:29 - 5314:30 - 5308:31 - 5302:31 - 5296:31 - 5290:32 - 5284:32 - 5278:32 - 5272:32 - 5266:34 - 5260:35 - 5254:37 - 5248:37 - 5242:38 - 5236:40 - 5230:41 - 5224:41 - 5218:41 - 5212:44 - 5206:44 - 5200:46 - 5194:64 - 5188:67 - 4956:like 4671:10 - 4665:10 - 4659:11 - 4653:11 - 4647:11 - 4641:12 - 4635:12 - 4629:13 - 4623:13 - 4617:14 - 4611:14 - 4605:15 - 4599:15 - 4593:17 - 4587:17 - 4581:18 - 4575:18 - 4569:18 - 4563:18 - 4557:19 - 4551:19 - 4545:19 - 4539:20 - 4533:20 - 4527:20 - 4521:21 - 4515:21 - 4509:21 - 4503:21 - 4497:21 - 4491:22 - 4485:23 - 4479:23 - 4473:24 - 4467:24 - 4461:25 - 4455:25 - 4449:27 - 4443:27 - 4437:28 - 4431:28 - 4425:28 - 4419:28 - 4413:29 - 4407:30 - 4401:31 - 4395:31 - 4389:31 - 4383:32 - 4377:32 - 4371:32 - 4365:32 - 4359:34 - 4353:35 - 4347:37 - 4341:37 - 4335:38 - 4329:40 - 4323:41 - 4317:41 - 4311:41 - 4305:44 - 4299:44 - 4293:46 - 4287:64 - 4281:67 - 4049:like 3900:lente 3529:Seppi 3490:Seppi 3000:1,106 2991:7,176 2988:4,215 2985:1,359 2932:Draft 2895:Start 2820:Seppi 2644:Seppi 1776:Seppi 1443:Seppi 1415:Sandy 1390:Seppi 1354:Seppi 1318:Seppi 1297:Sandy 1210:(aka 1062:TL;DR 1042:(34). 989:JSmol 985:(not 845:Jalap 804:Seppi 772:Seppi 741:Seppi 654:ā“ā“Ÿā“Ÿā“˜ā“§ 650:Note: 622:Brown 565:Brown 536:Brown 449:Seppi 366:Seppi 273:Seppi 247:Seppi 130:Seppi 16:< 5812:talk 5796:talk 5751:talk 5728:1 - 5722:1 - 5716:1 - 5710:2 - 5704:3 - 5698:3 - 5692:3 - 5686:3 - 5680:4 - 5674:5 - 5668:5 - 5662:5 - 5656:5 - 5650:5 - 5644:6 - 5638:6 - 5632:7 - 5626:7 - 5620:8 - 5614:8 - 5608:8 - 5602:9 - 5596:9 - 5590:9 - 5584:9 - 5179:talk 5148:talk 4970:talk 4905:talk 4889:talk 4844:talk 4821:1 - 4815:1 - 4809:1 - 4803:2 - 4797:3 - 4791:3 - 4785:3 - 4779:3 - 4773:4 - 4767:5 - 4761:5 - 4755:5 - 4749:5 - 4743:5 - 4737:6 - 4731:6 - 4725:7 - 4719:7 - 4713:8 - 4707:8 - 4701:8 - 4695:9 - 4689:9 - 4683:9 - 4677:9 - 4272:talk 4241:talk 4063:talk 4001:talk 3991:See 3958:talk 3946:here 3931:talk 3873:talk 3777:talk 3760:talk 3732:talk 3672:talk 3664:talk 3650:and 3613:talk 3581:here 3562:talk 3458:talk 3432:talk 3422:See 3414:talk 3366:talk 3252:talk 3118:talk 3085:here 3054:talk 2937:File 2917:List 2900:Stub 2781:talk 2767:talk 2748:talk 2717:talk 2703:talk 2631:talk 2561:talk 2519:this 2509:talk 2469:here 2443:talk 2428:talk 2381:talk 2349:here 2326:talk 2284:talk 2278:. -- 2217:talk 2155:talk 2108:time 2083:talk 2060:talk 1992:here 1938:talk 1884:here 1848:talk 1763:talk 1715:talk 1705:and 1683:talk 1606:here 1597:here 1553:talk 1538:talk 1508:talk 1437:|3}} 1423:Talk 1383:Done 1305:Talk 1277:Talk 1263:The 1220:talk 1200:and 1169:talk 1139:talk 1114:talk 1096:talk 977:Jmol 970:set. 853:talk 670:4th 658:Talk 562:. -- 479:talk 416:talk 338:talk 314:talk 228:talk 205:talk 158:talk 113:talk 5023:Bio 4116:Bio 3910:to 3902:to 3588:Bio 3533:333 3494:333 3389:Bio 3265:Bio 3223:Bio 3141:Bio 3092:Bio 3021:386 3018:928 2997:432 2982:608 2967:??? 2824:333 2759:one 2678:Bio 2648:333 2582:Bio 2526:Bio 2476:Bio 2403:Bio 2356:Bio 2351:. ā€• 2254:Bio 2191:Bio 2119:Bio 1999:Bio 1958:Bio 1899:Bio 1822:Bio 1780:333 1736:Bio 1447:333 1425:) 1394:333 1358:333 1322:333 1307:) 1084:). 997:to 960:300 915:In 849:pmj 808:333 776:333 745:333 630:ā€¢ ( 573:ā€¢ ( 544:ā€¢ ( 453:333 370:333 277:333 251:333 134:333 126:). 5814:) 5798:) 5774:}} 5768:{{ 5753:) 5181:) 5150:) 5030:šŸ™“ 4972:) 4907:) 4891:) 4867:}} 4861:{{ 4846:) 4274:) 4243:) 4123:šŸ™“ 4065:) 4003:) 3995:-- 3977:) 3960:) 3933:) 3875:) 3833:ā€” 3779:) 3762:) 3734:) 3718:ā†’ 3714:+ 3705:ā†’ 3701:+ 3674:) 3642:, 3615:) 3595:šŸ™“ 3564:) 3545:) 3542:2Ā¢ 3506:) 3503:2Ā¢ 3486:. 3460:) 3434:) 3416:) 3396:šŸ™“ 3372:) 3368:ā€¢ 3322:. 3272:šŸ™“ 3254:) 3230:šŸ™“ 3210:, 3206:, 3198:, 3148:šŸ™“ 3120:) 3099:šŸ™“ 3087:.ā€• 3060:) 3056:ā€¢ 3027:4 3024:26 3015:23 3009:44 3006:22 3003:13 2979:47 2973:11 2962:NA 2912:FL 2880:GA 2856:FA 2836:) 2833:2Ā¢ 2813:}} 2809:{{ 2798:}} 2794:{{ 2783:) 2769:) 2761:. 2750:) 2719:) 2705:) 2685:šŸ™“ 2660:) 2657:2Ā¢ 2633:) 2589:šŸ™“ 2563:) 2533:šŸ™“ 2511:) 2503:-- 2483:šŸ™“ 2445:) 2430:) 2410:šŸ™“ 2383:) 2363:šŸ™“ 2328:) 2286:) 2261:šŸ™“ 2219:) 2211:-- 2198:šŸ™“ 2157:) 2126:šŸ™“ 2085:) 2062:) 2006:šŸ™“ 1965:šŸ™“ 1940:) 1906:šŸ™“ 1850:) 1829:šŸ™“ 1792:) 1789:2Ā¢ 1765:) 1743:šŸ™“ 1717:) 1689:) 1685:ā€¢ 1653:ā€” 1648:. 1641:. 1628:. 1600:. 1591:. 1589:}} 1583:{{ 1555:) 1540:) 1510:) 1459:) 1456:2Ā¢ 1433:{{ 1406:) 1403:2Ā¢ 1370:) 1367:2Ā¢ 1350:. 1334:) 1331:2Ā¢ 1249:) 1243:Ed 1222:) 1208:}} 1202:{{ 1198:}} 1192:{{ 1171:) 1141:) 1116:) 1098:) 1034:, 958:10 950:}} 944:{{ 923:}} 917:{{ 900:) 894:Ed 871:) 865:Ed 855:) 820:) 817:2Ā¢ 800:. 788:) 785:2Ā¢ 768:. 757:) 754:2Ā¢ 481:) 465:) 462:2Ā¢ 418:) 382:) 379:2Ā¢ 344:) 340:ā€¢ 316:) 289:) 286:2Ā¢ 263:) 260:2Ā¢ 230:) 211:) 207:ā€¢ 172:- 160:) 146:) 143:2Ā¢ 115:) 64:ā† 5810:( 5794:( 5749:( 5177:( 5146:( 5033:ā¤ 4968:( 4903:( 4887:( 4842:( 4270:( 4239:( 4126:ā¤ 4061:( 3999:( 3973:( 3956:( 3929:( 3871:( 3775:( 3758:( 3730:( 3670:( 3662:( 3611:( 3598:ā¤ 3576:: 3572:@ 3560:( 3538:( 3499:( 3456:( 3430:( 3412:( 3399:ā¤ 3364:( 3289:: 3285:@ 3275:ā¤ 3250:( 3233:ā¤ 3166:: 3162:@ 3151:ā¤ 3116:( 3102:ā¤ 3073:: 3069:@ 3052:( 3012:0 2994:1 2976:0 2890:C 2885:B 2868:A 2829:( 2779:( 2765:( 2746:( 2715:( 2701:( 2688:ā¤ 2671:: 2667:@ 2653:( 2629:( 2592:ā¤ 2559:( 2536:ā¤ 2507:( 2486:ā¤ 2441:( 2426:( 2413:ā¤ 2379:( 2366:ā¤ 2340:: 2336:@ 2324:( 2293:ā€” 2282:( 2264:ā¤ 2230:: 2226:@ 2215:( 2201:ā¤ 2183:: 2179:@ 2168:: 2164:@ 2153:( 2129:ā¤ 2096:: 2092:@ 2081:( 2058:( 2025:: 2021:@ 2009:ā¤ 1984:: 1980:@ 1968:ā¤ 1951:: 1947:@ 1936:( 1909:ā¤ 1846:( 1832:ā¤ 1803:: 1799:@ 1785:( 1761:( 1746:ā¤ 1731:ā€• 1728:: 1724:@ 1713:( 1681:( 1551:( 1536:( 1506:( 1452:( 1421:( 1399:( 1363:( 1327:( 1303:( 1280:) 1274:( 1245:( 1235:: 1231:@ 1218:( 1167:( 1137:( 1112:( 1094:( 991:= 987:| 979:= 975:| 896:( 867:( 851:( 813:( 781:( 750:( 719:/ 715:/ 634:) 577:) 548:) 477:( 458:( 431:: 427:@ 414:( 393:: 389:@ 375:( 356:: 352:@ 336:( 312:( 282:( 256:( 241:: 237:@ 226:( 203:( 181:- 156:( 139:( 111:( 50:.

Index

Knowledge talk:WikiProject Pharmacology
archive
current talk page
ArchiveĀ 10
ArchiveĀ 12
ArchiveĀ 13
ArchiveĀ 14
ArchiveĀ 15
ArchiveĀ 16
ArchiveĀ 17
Wowbagger2
talk
17:23, 29 December 2017 (UTC)
special:diff/764891086/765098473
Seppi333
InsertĀ 2Ā¢
20:24, 29 December 2017 (UTC)
DePiep
talk
01:35, 30 December 2017 (UTC)
Copanlisib
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=209936
Acalabrutinib
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=210259
unsigned
Wowbagger2
talk
contribs
11:38, 30 December 2017 (UTC)

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

ā†‘